WO2001036371A1 - Carbonic acid derivatives and their use as ectoparasiticidal composition - Google Patents

Carbonic acid derivatives and their use as ectoparasiticidal composition Download PDF

Info

Publication number
WO2001036371A1
WO2001036371A1 PCT/EP2000/011470 EP0011470W WO0136371A1 WO 2001036371 A1 WO2001036371 A1 WO 2001036371A1 EP 0011470 W EP0011470 W EP 0011470W WO 0136371 A1 WO0136371 A1 WO 0136371A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compound
hydrogen
halogen
alkyl
Prior art date
Application number
PCT/EP2000/011470
Other languages
French (fr)
Inventor
Pierre Ducray
Jacques Bouvier
Roland Kaminsky
Olivier Froelich
Original Assignee
Novartis Ag
Novartis-Erfindungen Verwaltungsgesellschaft Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Novartis-Erfindungen Verwaltungsgesellschaft Mbh filed Critical Novartis Ag
Priority to AU21601/01A priority Critical patent/AU2160101A/en
Publication of WO2001036371A1 publication Critical patent/WO2001036371A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96Esters of carbonic or haloformic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/20Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/45Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/55Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and esterified hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/04Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers
    • C07C257/08Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers having carbon atoms of imino-carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62Halogen-containing esters
    • C07C69/65Halogen-containing esters of unsaturated acids

Definitions

  • the present invention relates to new compounds of formula I, to their preparation and to their use in controlling ectoparasites on domestic animals, productive livestock and pets, also to ectoparasiticidal compositions for use on such animals, the compositions comprising at least one such compound as active ingredient, and to the use of such substances in the preparation of the said compositions.
  • Ri and R 2 are each independently of the other hydrogen, halogen, cyano, nitro, C 1-4 alkyl, C ⁇ . 4 alkoxy, C ⁇ . haloalkoxy or benzyl;
  • A is oxygen, sulfur or -N(R 6 )-, wherein R 6 is d. alkyl, phenylthio or tolylthio;
  • B is -C(O)-, -O-C(O)- or -C(N-R 6 )-, wherein n is 0 or 1 and R 6 is hydrogen or C 1-4 alkyl; p is an integer from 1 to 10;
  • R 3 , R 4 and R 5 are each independently of the others hydrogen, halogen, cyano, nitro,
  • R 3 and R are adjacent to one another and together with the phenyl ring to which they are bonded form a naphthyl group; m is 0, 1 , 2 or 3; and Z is C ⁇ -6 alkyl, phenyl or halogen; in free form or in the form of physiologically tolerable salts.
  • Ri and R 2 are hydrogen; A is oxygen; n is 1 , m is 2; p is 3; and Z is
  • the bridge -(B)n-O- preferably forms the group -C(O)-O-,
  • Alkyl on its own or as a constituent of a haloalkyl, alkoxy or haloalkoxy radical is to be understood as meaning a saturated, unbranched or branched hydrocarbon radical having from one to four carbon atoms, for example a substituent such as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl or tert-butyl.
  • halo indicates that the substituent in question is partially or completely halogenated.
  • haloalkyl - as a group perse or as a structural element of other groups and compounds, such as of haloalkoxy - are methyl substituted from one to three times by fluorine, chlorine and/or bromine, such as CHF or CF 3 ; ethyl substituted from one to five times by fluorine, chlorine and/or bromine, such as CH 2 CF 3 , CF 2 CF 3 , CF 2 CCI 3 , CF 2 CHCI 2 , CF 2 CHF 2 , CF 2 CFCI 2 , CF 2 CHBr 2 , CF 2 CHCIF, CF 2 CHBrF or CCIFCHCIF; propyl or isopropyl substituted from one to seven times by fluorine, chlorine and/or bromine, such as CH 2 CHBrCH 2 Br, CF 2 CHFCF 3 , CH 2 CF 2 CF 3 or CH(CF 3 ) 2 ; and butyl or an isomer thereof substituted from
  • halo and halogen denote halogen atoms and are generally fluorine, chlorine, bromine or iodine, preferably fluorine or chlorine; as a substituent of an alkyl group they denote especially fluorine, and as a substituent of a phenyl ring they denote especially chlorine.
  • R ⁇ and R 2 are each independently of the other hydrogen, halogen or C ⁇ . 4 alkyl;
  • A is oxygen, sulfur or -N(R 6 )-, wherein R 6 is C 1- alkyl;
  • R 3 , R 4 and R 5 are each independently of the others hydrogen, halogen, cyano, nitro, C 1-4 alkyl or C ⁇ - alkoxy; and
  • Z is d- ⁇ alkyl, phenyl or halogen; in free form or in the form of physiologically tolerable salts.
  • R ⁇ and R 2 are each independently of the other hydrogen, fluorine, chlorine or C ⁇ -4 alkyl; with the proviso that both are not simultaneously hydrogen;
  • A is oxygen;
  • R 3 , R 4 and R 5 are each independently of the others hydrogen, fluorine, chlorine, CF 3 , cyano or nitro;
  • Z is CH 3 , phenyl, fluorine or chlorine; in free form or in the form of physiologically tolerable salts.
  • Z is CH 3 are more especially preferred.
  • the present invention relates also to the preparation of compounds of formula I, which is carried out by reacting a compound of formula II
  • R, R 1 ( R 2 , B, A, n and m are as defined for formula I, in the presence or absence of an inert solvent or solvent mixture, with a compound of formula III
  • Q is hydroxy or halogen and p is as defined for formula I, preferably chlorine or bromine; and Z and p are as defined for formula I; the reaction preferably being carried out in the presence of a hydrophilic agent or of a catalyst when Q is hydroxy, and preferably being carried out in the presence of an acid-binding agent when Q is halogen.
  • reaction of II with a compound of formula III wherein Q is halogen is preferably carried out in an inert, hydroxyl-group-free solvent in the presence of an organic base, for example pyridine, 4-dimethylaminopyridine, lutidine, collidine, trialkylamine or N,N-dialkylaniline, or of a bicyclic, non-nucleophilic base, such as 1 ,4-diazabicyclo[2.2.2]octane (DABCO), 1 ,5- diazabicyclo[4.3.0]non-5-ene (DBN) or 1 ,8-diazabicyclo[5.4.0]undec-7-ene (1 ,5-5) (DBU).
  • an organic base for example pyridine, 4-dimethylaminopyridine, lutidine, collidine, trialkylamine or N,N-dialkylaniline, or of a bicyclic, non-nucleophilic base, such as 1 ,4-d
  • the reaction is generally carried out at temperatures of from -30°C to +70°C, preferably from -10°C to +50°C.
  • Suitable solvents include, for example, aliphatic and aromatic hydrocarbons, such as benzene, toluene, xylenes, petroleum ether and hexane; halogenated hydrocarbons, such as chlorobenzene, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride and tetrachloro- ethylene; ethers and ether-type compounds, such as dialkyl ethers (diethyl ether, diisopropyl ether, tert-butyl methyl ether, etc.), anisole, dioxane and tetrahydrofuran; nitriles, such as acetonitrile and propionitrile; esters, such as ethylenes, benzene, toluene, xylenes, petroleum ether
  • reaction of II with a compound of formula III wherein Q is hydroxy is advantageously carried out in the presence of water- re moving reagents customary for esterification, for example in the presence of a carbodiimide [dicyclohexylcarbodiimide (DCC)] or of a 1-alkyl- 2-halopyridinium salt, such as 1 -methyl-2-chloropyridinium iodide.
  • DCC dicyclohexylcarbodiimide
  • a 1-alkyl- 2-halopyridinium salt such as 1 -methyl-2-chloropyridinium iodide.
  • the reaction is in that case advantageously carried out at temperatures of from -30°C to +70°C, preferably from -10°C to +50°C, in the presence of a solvent or solvent mixture that is inert to the reaction.
  • the reaction is preferably carried out in the presence of a base, for example in the presence of an organic amine, such as a trialkylamine (trimethylamine, triethylamine, tripropylamine or diisopropylethylamine), a pyridine (pyridine itself, 4-dimethylaminopyridine or 4-pyrrolidinopyridine), a morpholine (N-methylmorpholine) or an N,N-dialkylaniline (N,N- dimethylaniline or N-methyl-N-ethylaniline).
  • an organic amine such as a trialkylamine (trimethylamine, triethylamine, tripropylamine or diisopropylethylamine), a pyridine (pyridine itself, 4-dimethylaminopyridine or 4-pyrrolidinopyridine), a morpholine (N-methylmorpholine) or an N,N-dialkylaniline (N,N- dimethylaniline or N-methyl-N-e
  • Suitable solvents include, for example, aliphatic and aromatic hydrocarbons, such as benzene, toluene, xylenes, petroleum ether and hexane; halogenated hydrocarbons, such as chlorobenzene, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride and tetrachloroethylene; ether and ether-type compounds, such as dialkyl ethers (diethyl ether, diisopropyl ether, tert-butyl methyl ether, etc.), anisole, dioxane and tetrahydrofuran; nitriles, such as acetonitrile and propionitrile; esters, such as ethyl acetate (acetic acid ethyl ester), propyl acetate and butyl acetate; and mixtures of such solvents with one another.
  • aliphatic and aromatic hydrocarbons such as benzene, tol
  • the conversion of free compounds I into salts and of salts into free compounds I or into other salts is effected in customary manner, e.g. by treatment of a free compound I with an acid, or of a salt with a base.
  • Example 1 Preparation of 4-methyl-5.5-difluoropent-4-enoic acid ⁇ 2-[4-(4-trifluoromethyl- phenoxy)phenoxy1ethyl) ester of the formula
  • ectoparasites are understood to mean in particular insects, mites and ticks. Included are insects of the following orders: Lepidoptera, Coleoptera, Homoptera, Heteroptera, Diptera, Thysanoptera, O ⁇ hoptera, Psoroptes, Anoplura, Siphonaptera, Mallophaga, Thysanura, Isoptera, Psocoptera and Hymenoptera.
  • ectoparasites that trouble humans and animals and transmit pathogens
  • pathogens for example flies, such as Musca domestica, Musca vetustissima, Musca autumnalis, Fannia canicularis, Sarcophaga carnaria, Lucilia cuprina, Hypoderma bovis, Hypoderma lineatum, Chrysomyia chloropyga, Dermatobia hominis, Cochliomyia hominivorax, Gasterophilus intestinalis, Oestrus ovis, Stomoxys calcitrans, Haematobia irritans and midges (Nematocera), such as Culicidae, Simuliidae, Psychodidae, and also bloodsucking parasites, for example fleas, such as Ctenocephalides felis and Ctenocephalides canis (cat and dog fleas), Xenopsylla cheopis, Pulex irritans, Dermatophilus
  • ticks are, for example, Boophilus, Amblyomma, Anocentor, Dermacentor, Haemaphysalis, Hyalomma, Ixodes, Rhipicentor, Margaropus, Rhipicephalus, Argas, Otobius and Ornithodoros and the like that preferentially infest warm-blooded animals, including farm animals, such as cows, pigs, sheep and goats, poultry, such as hens, turkeys and geese, animals bred for their fur, such as mink, fox, chinchillas, rabbits and the like, and domestic animals, such as cats and dogs, but also humans.
  • farm animals such as cows, pigs, sheep and goats
  • poultry such as hens, turkeys and geese
  • animals bred for their fur such as mink, fox, chinchillas, rabbits and the like
  • domestic animals such as cats and dogs, but also humans.
  • Ticks may be subdivided into hard and soft ticks and are characterised by the fact that they infest one, two or three host animals. They attach themselves to a suitable host animal and suck blood or body fluid. Fully replete female ticks fall off the host animal and lay large amounts of eggs (2000 to 3000) in a suitable niche in the ground or in any other protected site, where the larvae hatch out. These in turn look for a host animal from which to suck blood. Larvae of ticks that infest only one host animal moult twice and in so doing become nymphs and finally adult ticks without leaving the host animal initially selected. Larvae of ticks that infest two or three host animals fall off after the blood meal, moult in the surrounding area and, as nymphs or adult ticks, look for a second or third host on which to suck.
  • Ticks are responsible worldwide for carrying and transmitting many human and animal diseases.
  • the most significant ticks owing to their economic effect, are Boophilus, Rhipicephalus, Ixodes, Hyalomma, Amblyomma and Dermacentor. They are carriers of bacterial, viral, rickettsial and protozoal diseases and cause tick paralysis and tick toxicosis. Just a single tick can cause paralysis as a result of its saliva penetrating the host animal as the tick takes its nourishment. Diseases triggered by ticks are usually carried by ticks that infest a plurality of host animals.
  • ticks are responsible for the death of, or injury to, a large number of domestic and farm animals worldwide.
  • ixodid ticks transmit the agent of chronically damaging Lyme disease from wild animals to humans.
  • ticks are responsible for large-scale economic loss in livestock production. The losses are attributable not only to the death of the host animals but also to damage to the coats, growth loss, reduction in milk production and the reduced value of the meat.
  • fleas are not only a nuisance but are also disease carriers that, especially in moist-warm climatic regions, for example in the Mediterranean region, the southern part of the USA, etc., transmit various fungal diseases from host animal to host animal and to the animal keeper. Especially at risk are people having a weakened immune system or children whose immune system has not yet fully developed.
  • the present invention accordingly preferably relates to a method of controlling parasites on or in domestic animals, productive livestock and pets, which method comprises administering an effective amount of a composition that comprises at least one compound of formula I or a physiologically tolerable salt thereof, preferably topically, to an infested warm-blooded animal for curative treatment or to a parasite-free warm-blooded animal for preventative treatment.
  • pour-on and spot-on formulations are especially preferred forms of topical administration, but administration in the form of sprays, ointments, solutions, baths or powders may also be expedient.
  • the compound of formula I according to the invention will normally be administered not in pure form but preferably in the form of a composition that comprises, in addition to the active ingredient, constituents that assist administration, suitable constituents being those which are tolerated by the host animal.
  • the control according to the invention covers both the adult parasites and the juvenile stages of the parasites. Further active substances may of course be added to such compositions in order to broaden the spectrum of activity of the active ingredient.
  • compositions to be administered in accordance with the invention generally comprise from 0.1 to 99% by weight, especially from 0.1 to 95% by weight, of a compound of formula I according to the invention and from 99.9 to 1 % by weight, especially from 99.9 to 5% by weight, of a solid or liquid, physiologically tolerable carrier, including from 0 to 25% by weight, especially from 0.1 to 25% by weight, of a non-toxic dispersant.
  • a solid or liquid, physiologically tolerable carrier including from 0 to 25% by weight, especially from 0.1 to 25% by weight, of a non-toxic dispersant.
  • compositions may comprise further additives, such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as other active ingredients for obtaining special effects.
  • additives such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as other active ingredients for obtaining special effects.
  • physiologically tolerable carriers known from veterinary medicinal practice for oral, percutaneous and topical administration can be used as formulation auxiliaries. Some examples are given below.
  • Suitable carriers are especially fillers, such as sugars, for example lactose, saccharose, mannitol or sorbitol, cellulose preparations and/or calcium phosphates, for example tricalcium phosphate or calcium hydrogen phosphate, and binders, such as starch pastes using, for example, maize, wheat, rice or potato starch, gelatins, tragacanth, methyl cellulose and/or, if desired, disintegrators, such as the above-mentioned starches, also carboxymethyl starch, crosslinked polyvinylpyrrolidone, agar, alginic acid or a salt thereof, such as sodium alginate.
  • fillers such as sugars, for example lactose, saccharose, mannitol or sorbitol, cellulose preparations and/or calcium phosphates, for example tricalcium phosphate or calcium hydrogen phosphate
  • binders such as starch pastes using, for example, maize, wheat, rice or potato star
  • Adjuvants are especially flow regulators and lubricants, for example silicic acid, talc, stearic acid or salts thereof, such as magnesium or calcium stearate, and/or polyethylene glycol.
  • Dragee cores can be provided with suitable, optionally enteric, coatings, there being used, inter alia, concentrated sugar solutions which may comprise gum arabic, talc, polyvinylpyrrolidone, polyethylene glycol and/or titanium dioxide, or coating solutions in suitable organic solvents or solvent mixtures or, for the preparation of enteric coatings, solutions of suitable cellulose preparations, such as acetyl cellulose phthalate or hydroxypropylmethylcellulose phthalate. Dyes, flavourings or pigments may be added to the tablets or dragee coatings, for example for identification purposes or to indicate different doses of active ingredient.
  • the preferred pour-on or spot-on method comprises applying the compound of formula I to a locally defined area of the skin or coat, advantageously on the back of the neck or the backbone of the animal. This is carried out, for example, by applying a swab or squirt of the pour-on or spot-on formulation to a relatively small area of the coat from where the active ingredient becomes distributed over a wide area of the coat almost automatically, as a result of the spreading constituents of the formulation and assisted by the movements of the animal.
  • Pour-on and spot-on formulations advantageously comprise carriers that promote rapid distribution over the surface of the skin or in the coat of the host animal and are generally termed spreading oils.
  • suitable oils for example, oily solutions; alcoholic and isopropanolic solutions, e.g.
  • solutions of 2-octyldodecanol or oleyl alcohol solutions in esters of monocarboxylic acids, such as isopropyl myristate, isopropyl palmitate, lauric acid oxalic ester, oleic acid oleyl ester, oleic acid decyl ester, hexyl laurate, oleyl oleate, decyl oleate, capric acid esters of saturated fatty alcohols of chain length C 12 -C ⁇ 8 ; solutions of esters of dicarboxylic acids, such as dibutyl phthalate, diisopropyl isophthalate, adipic acid diisopropyl ester, di-n-butyl adipate or solutions of esters of aliphatic acids, e.g.
  • glycols It may be advantageous for a dispersant known from the pharmaceutical or cosmetic industry also to be present.
  • a dispersant known from the pharmaceutical or cosmetic industry also to be present. Examples are pyrrolidin-2-one, N-alkylpyrrolidin-2-one, acetone, polyethylene glycol and its ethers and esters, propylene glycol and synthetic triglycerides.
  • the oily solutions include e.g. vegetable oils, such as olive oil, groundnut oil, sesame oil, pine oil, linseed oil and castor oil.
  • vegetable oils may also be in epoxidised form. It is also possible to use paraffins and silicone oils.
  • a pour-on or spot-on formulation will contain from 1 to 20% by weight of a compound of formula (I), from 0.1 to 50% by weight of dispersant and from 45 to 98.9% by weight of solvent.
  • the pour-on or spot-on method can be used especially advantageously for herd animals, such as cattle, horses, sheep and pigs, where it is difficult or time-consuming to treat all the animals orally or via injection.
  • this method can of course also be used for all other animals, including individual domestic animals and pets, and is very popular with the keepers of animals because it can often be carried out without the expert assistance of a veterinary surgeon.
  • the preparations of the present invention can be prepared in a manner known per se, for example by means of conventional processes.
  • A. compound of formula 1 10% epoxidised soybean oil 5% oleyl alcohol 85%
  • the constituents are mixed and ground with one another until homogeneous.
  • Suspension concentrates compound of formula I : from 5 to 75 %, preferably from 10 to 50 % water: from 94 to 24 %, preferably from 88 to 30 % surfactant: from 1 to 40 %, preferably from 2 to 30 %
  • compositions may also comprise further additives, such as stabilisers, e.g. vegetable oils or epoxidised vegetable oils (epoxidised coconut oil, rape oil or soybean oil), antifoams, e.g. silicone oil, preservatives, viscosity regulators, binders and tackifiers, as well as fertilisers, or other active ingredients for obtaining special effects.
  • stabilisers e.g. vegetable oils or epoxidised vegetable oils (epoxidised coconut oil, rape oil or soybean oil)
  • antifoams e.g. silicone oil
  • preservatives e.g. silicone oil
  • viscosity regulators e.g. binders and tackifiers
  • fertilisers e.g., binders and tackifiers
  • the compounds of formula I according to the invention can be used alone or in combination with other biocides.
  • biocides for example, in order to enhance their effect they can be combined with pesticides having the same direction of action or in order to broaden the spectrum of activity they can be combined with substances having a different direction of action. It may also be advantageous to add repellents.
  • the compounds of formula I are advantageously combined with substances having endoparasiticidal properties. They can, of course, also be used in combination with anti-bacterial compositions. Since the compounds of formula I are 31
  • Suitable mixing partners are biocides, such as the insecticides and acaricides mentioned hereinbelow that are sufficiently well known to the person skilled in the art and that have various action mechanisms, e.g. chitin synthesis inhibitors, growth regulators; active ingredients that act like juvenile hormones; active ingredients that act as adulticides; broad- spectrum insecticides, broad-spectrum acaricides and nematicides; and also the sufficiently well known anthelmintics and substances that repel insects and/or acarina, so-called repellents and detachers.
  • suitable insecticides and acaricides are:
  • Non-limiting examples of suitable repelling substances are:
  • XXXVI S-tert-butylthiomethyl 0,0-dimethyl phosphorodithioate (terbufos), from The Pesticide Manual, 1 1 th Ed. (1997), The British Crop Protection Council, London, page 1165;
  • XXXVII ethyl (3-ferf-butyl-1 -dimethylcarbamoyl-1 H-1 ,2,4-triazol-5-yl-thio)-acetate, (triazamate), from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 1224;
  • Pesticide Manual 1 1 th Ed. (1997), The British Crop Protection Council, London, page 507;
  • XLVII 4-phenoxyphenyl (r?S)-2-(pyridyloxy)propyl ether (pyriproxyfen), from The Pesticide
  • LV a preparation comprising insect-active fungi, preferably Verticillium lecanii, from The Pesticide Manual, 1 1 th Ed. (1997), The British Crop Protection Council, London, page 1266; Beauveria brogniartii, from The Pesticide Manual, 1 1 th Ed. (1997), The British Crop Protection Council, London, page 85; and Beauveria bassiana, from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 83;
  • LPI a preparation comprising insect-active viruses, preferably Neodipridon SertiferNPV, from The Pesticide Manual, 1 1 th Ed. (1997), The British Crop Protection Council, London, page 1342; Mamestra brassicae NPV, from The Pesticide Manual, 1 1 ⁇ Ed. (1997), The British Crop Protection Council, London, page 759; and Cydia pomonella granulosis virus, from The Pesticide Manual, 1 1 th Ed. (1997), The British Crop Protection Council,
  • a further substantial aspect of the present invention relates to combination preparations for the control of parasites on warm-blooded animals, which combination preparations comprise, in addition to a compound of formula I, at least one further active ingredient having the same direction of action or a different direction of action and at least one physiologically tolerable carrier.
  • the present invention is not limited to combinations of two constituents.
  • Blood samples are taken 6 hours after treatment and once each morning on the days that follow and are evaluated according to the following parameters.
  • Chemical values erythrocytes (RBC) aspartate aminotransferase (ASAT) haemoglobin (HB) alanine aminotransferase (ALAT) mean cell volume (HCT) creatine kinase (CK/NAC) mean cell-haemoglobin (MCH) ⁇ -glutamate transpeptidase (G-GT) mean cell-haemoglobin concentration total bilirubin (TBILI)
  • MCHC leucocytes
  • WBC creatinine
  • CREA blood platelets
  • PHT glucose
  • GLUC glucose
  • PHT glutamate dehydrogenase
  • BUN blood-urea-nitrogen
  • TOT. PROTEIN albumin
  • ALB globulin
  • GLOB globulin
  • NA sodium
  • K calcium
  • CA calcium
  • test substances do not at any time prove to cause local side- effects and the blood and chemical values measured show a range of variation absolutely identical to that for the untreated control animals.
  • the compounds of formula I e.g. compounds 1.01 , 1.06, 1.16, 1.22 and 3.01 , prove to be well tolerated up to a dose of 50 mg/kg under the test conditions.
  • Example 2 In vivo activity against mange mites on sheep after pour-on application Healthy sheep having an average body weight of approximately 35 kg are artificially infested, between the shoulder blades and in the groin area, with mange (Psoroptes ovis) of all stages of development. After 3 weeks, approximately 90% of the sheep have infested areas of skin of about 25 - 50 cm 2 . The infested sheep are selected for the remaining tests and, in order to be able to distinguish clearly between them, they are provided with numbered eartags. For the entire duration of the test, the sheep are kept in individual pens (0.9 x 1.2 m) having a slatted grid floor.
  • Example 3 In vivo action against mouse mites by topical treatment Mice infested with mites (Myocopetes musculinus and Myobia musculi) are anaesthetised and studied under a stereomicroscope to determine the density of the mite population. The mice are divided into groups having the same index of infestation, that is to say each having the same mite population, the index consisting of a scale from 1 (no mites) to 30 (greatest mite density). For the purposes of the test, only mice that score at least 25 on the said scale (high mite density) are used. The test substance is applied to the coat in the form of a solution, suspension or emulsion as a pour-on formulation, that is to say, topically.
  • the dose is in the range from 32 to 0.1 mg/kg of body weight.
  • 150 ⁇ l of the solution, suspension or emulsion are applied to each mouse along the line of the back.
  • the effectiveness is evaluated 7, 28 and 56 days after application by comparing the infestation index after treatment with that before treatment.
  • the effectiveness result is given as a percentage reduction in the mite population.
  • compounds of formula I from Tables 1 to 3 for example compounds 1.01 , 1.06, 1.16, 1.22 and 3.01 , at a dilution of up to 10 mg/kg of body weight, exhibit a more than 80% reduction in mite infestation and show no negative side- effects even at the highest active ingredient concentrations.

Abstract

There are described new compounds of formula (I) wherein, when n is 0, at least one of the two phenyl rings is substituted; R1 and R2 are each independently of the other hydrogen, halogen, cyano, nitro, C1-4alkyl, C1-4haloalkyl, C1-4alkoxy, C1-4 haloalkoxy or benzyl; A is oxygen, sulfur or -N(R6)-, wherein R6 is C1-4alkyl, phenylthio or tolylthio; B is -C(O)-, -O-C(O)- or -C(N-R6)-, wherein n is 0 or 1 and R6 is hydrogen of C1-4alkyl; p is an integer from 1 to 10; R3, R4 and R5 are each independently of the others hydrogen, halogen, cyano, nitro, C1-4alkyl, C1-4haloalkyl, C1-4alkoxy or C1-4haloalkoxy; or R3 and R4 are adjacent to one another and together with the phenyl ring to which they are bonded form a naphthyl group; m is 0, 1, 2 or 3; and Z is C1-6 alkyl, phenyl or halogen; in free form or in the form of physiologically tolerable salts. Also described is the preparation of those substances and their use in controlling ectoparasites on domestic animals, productive livestock and pets, as well as ectoparasiticidal compositions for use on such animals.

Description

CARBONIC ACID DERIVATIVES AND THEIR USE AS ECTOPARASITICIDAL COMPOSITION
The present invention relates to new compounds of formula I, to their preparation and to their use in controlling ectoparasites on domestic animals, productive livestock and pets, also to ectoparasiticidal compositions for use on such animals, the compositions comprising at least one such compound as active ingredient, and to the use of such substances in the preparation of the said compositions.
The substances according to the invention are compounds of formula I
Figure imgf000002_0001
wherein, when n is 0, at least one of the two phenyl rings is substituted;
Ri and R2 are each independently of the other hydrogen, halogen, cyano, nitro, C1-4alkyl,
Figure imgf000002_0002
Cι.4alkoxy, Cι. haloalkoxy or benzyl;
A is oxygen, sulfur or -N(R6)-, wherein R6 is d. alkyl, phenylthio or tolylthio;
B is -C(O)-, -O-C(O)- or -C(N-R6)-, wherein n is 0 or 1 and R6 is hydrogen or C1-4alkyl; p is an integer from 1 to 10;
R3, R4 and R5 are each independently of the others hydrogen, halogen, cyano, nitro,
Cι.4alkyl, Cι-4haloalkyl, Cι-4alkoxy or C^haloalkoxy; or R3 and R are adjacent to one another and together with the phenyl ring to which they are bonded form a naphthyl group; m is 0, 1 , 2 or 3; and Z is Cι-6alkyl, phenyl or halogen; in free form or in the form of physiologically tolerable salts. Preference is given to compounds wherein Ri and R2 are hydrogen; A is oxygen; n is 1 , m is 2; p is 3; and Z is
CH3 or F. In cases in which n is 1 , the bridge -(B)n-O- preferably forms the group -C(O)-O-,
-O-C(O)-O- or -C(N-R6)-O- .
"Alkyl" on its own or as a constituent of a haloalkyl, alkoxy or haloalkoxy radical is to be understood as meaning a saturated, unbranched or branched hydrocarbon radical having from one to four carbon atoms, for example a substituent such as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl or tert-butyl. The prefix "halo" indicates that the substituent in question is partially or completely halogenated. Examples of haloalkyl - as a group perse or as a structural element of other groups and compounds, such as of haloalkoxy - are methyl substituted from one to three times by fluorine, chlorine and/or bromine, such as CHF or CF3; ethyl substituted from one to five times by fluorine, chlorine and/or bromine, such as CH2CF3, CF2CF3, CF2CCI3, CF2CHCI2, CF2CHF2, CF2CFCI2, CF2CHBr2, CF2CHCIF, CF2CHBrF or CCIFCHCIF; propyl or isopropyl substituted from one to seven times by fluorine, chlorine and/or bromine, such as CH2CHBrCH2Br, CF2CHFCF3, CH2CF2CF3 or CH(CF3) 2; and butyl or an isomer thereof substituted from one to nine times by fluorine, chlorine and/or bromine, such as CF(CF3)CHFCF3 or CH2(CF2)2CF3. The terms "halo" and "halogen" denote halogen atoms and are generally fluorine, chlorine, bromine or iodine, preferably fluorine or chlorine; as a substituent of an alkyl group they denote especially fluorine, and as a substituent of a phenyl ring they denote especially chlorine.
Owing to their especially pronounced activity, within the context of formula I there are especially preferred sub-groups, such as, for example, the group of compounds of formula la
Figure imgf000003_0001
wherein R^ and R2 are each independently of the other hydrogen, halogen or Cι.4alkyl; A is oxygen, sulfur or -N(R6)-, wherein R6 is C1- alkyl; R3, R4 and R5 are each independently of the others hydrogen, halogen, cyano, nitro, C1-4alkyl or Cι- alkoxy; and Z is d-βalkyl, phenyl or halogen; in free form or in the form of physiologically tolerable salts. Within the context of formula la, special preference is given to those compounds wherein R^ and R2 are each independently of the other hydrogen, fluorine, chlorine or Cι-4alkyl; with the proviso that both are not simultaneously hydrogen; A is oxygen; R3, R4 and R5 are each independently of the others hydrogen, fluorine, chlorine, CF3, cyano or nitro; and Z is CH3, phenyl, fluorine or chlorine; in free form or in the form of physiologically tolerable salts. Those compounds wherein Z is CH3 are more especially preferred. Within the context of the present invention, special preference is given to each of the individual compounds mentioned hereinbelow:
4-methyl-5,5-difluoropent-4-enoic acid {2-[4-(3-n-propylphenoxy)phenoxy]ethyl} ester; 4-methyl-5,5-difluoropent-4-enoic acid {2-[4-(3-chlorophenoxy)phenoxy]ethyl} ester; 4-methyl-5,5-difluoropent-4-enoic acid {2-[4-(4-trifluoromethylphenoxy)phenoxy]ethyl} ester; 4-methyl-5,5-difluoropent-4-enoic acid {2-[4-(3,5-dichlorophenoxy)phenoxy]ethyl} ester; and 4-methyl-5,5-difluoropent-4-enoic acid {2-[4-(4-phenoxycarbonyloxy)phenoxy]ethyl} ester.
Compounds of that structural type are included in EP-0 577 555 but are not specifically disclosed therein. The substances described therein are presented as active ingredients in the field of pest control, especially for use against insects and arachnids, such as occur on crops of useful plants and ornamentals in agriculture and in horticulture, especially in crops of rice, cotton, vegetables and fruits, and in forestry. As further fields of application mention is made of their use in the field of hygiene, in the protection of raw materials and in the protection of domestic animals and productive livestock, but those uses are not described.
The present invention relates also to the preparation of compounds of formula I, which is carried out by reacting a compound of formula II
Figure imgf000004_0001
wherein R, R1 ( R2, B, A, n and m are as defined for formula I, in the presence or absence of an inert solvent or solvent mixture, with a compound of formula III
Figure imgf000004_0002
wherein Q is hydroxy or halogen and p is as defined for formula I, preferably chlorine or bromine; and Z and p are as defined for formula I; the reaction preferably being carried out in the presence of a hydrophilic agent or of a catalyst when Q is hydroxy, and preferably being carried out in the presence of an acid-binding agent when Q is halogen. The reaction of II with a compound of formula III wherein Q is halogen is preferably carried out in an inert, hydroxyl-group-free solvent in the presence of an organic base, for example pyridine, 4-dimethylaminopyridine, lutidine, collidine, trialkylamine or N,N-dialkylaniline, or of a bicyclic, non-nucleophilic base, such as 1 ,4-diazabicyclo[2.2.2]octane (DABCO), 1 ,5- diazabicyclo[4.3.0]non-5-ene (DBN) or 1 ,8-diazabicyclo[5.4.0]undec-7-ene (1 ,5-5) (DBU). The reaction is generally carried out at temperatures of from -30°C to +70°C, preferably from -10°C to +50°C. The reaction is advantageously carried out in the presence of a solvent or solvent mixture that is inert to the reaction. Suitable solvents include, for example, aliphatic and aromatic hydrocarbons, such as benzene, toluene, xylenes, petroleum ether and hexane; halogenated hydrocarbons, such as chlorobenzene, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride and tetrachloro- ethylene; ethers and ether-type compounds, such as dialkyl ethers (diethyl ether, diisopropyl ether, tert-butyl methyl ether, etc.), anisole, dioxane and tetrahydrofuran; nitriles, such as acetonitrile and propionitrile; esters, such as ethyl acetate (acetic acid ethyl ester), propyl acetate and butyl acetate; ketones, such as acetone, diethyl ketone and methyl ethyl ketone; and mixtures of such solvents with one another. The reaction is normally carried out at ambient pressure, but can also be carried out at elevated or reduced pressure.
The reaction of II with a compound of formula III wherein Q is hydroxy is advantageously carried out in the presence of water- re moving reagents customary for esterification, for example in the presence of a carbodiimide [dicyclohexylcarbodiimide (DCC)] or of a 1-alkyl- 2-halopyridinium salt, such as 1 -methyl-2-chloropyridinium iodide. The reaction is in that case advantageously carried out at temperatures of from -30°C to +70°C, preferably from -10°C to +50°C, in the presence of a solvent or solvent mixture that is inert to the reaction. The reaction is preferably carried out in the presence of a base, for example in the presence of an organic amine, such as a trialkylamine (trimethylamine, triethylamine, tripropylamine or diisopropylethylamine), a pyridine (pyridine itself, 4-dimethylaminopyridine or 4-pyrrolidinopyridine), a morpholine (N-methylmorpholine) or an N,N-dialkylaniline (N,N- dimethylaniline or N-methyl-N-ethylaniline). Suitable solvents include, for example, aliphatic and aromatic hydrocarbons, such as benzene, toluene, xylenes, petroleum ether and hexane; halogenated hydrocarbons, such as chlorobenzene, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride and tetrachloroethylene; ether and ether-type compounds, such as dialkyl ethers (diethyl ether, diisopropyl ether, tert-butyl methyl ether, etc.), anisole, dioxane and tetrahydrofuran; nitriles, such as acetonitrile and propionitrile; esters, such as ethyl acetate (acetic acid ethyl ester), propyl acetate and butyl acetate; and mixtures of such solvents with one another.
The conversion of free compounds I into salts and of salts into free compounds I or into other salts is effected in customary manner, e.g. by treatment of a free compound I with an acid, or of a salt with a base.
Compounds of the type of formulae II and III and their preparation are known from the literature or they can be prepared analogously to known examples. Compounds III can also be prepared according to the processes described in US-4 950 666 and EP-A-0 432 861. It is also possible to work in accordance with the procedures described in EP-0 577 555, pages 5 - 8.
Preparation Examples
Example 1 : Preparation of 4-methyl-5.5-difluoropent-4-enoic acid {2-[4-(4-trifluoromethyl- phenoxy)phenoxy1ethyl) ester of the formula
Figure imgf000006_0001
4 g of 5,5-difluoropent-4-enoic acid chloride are added in portions, with ice-cooling, to a solution of 5.8 g of 2-{4-(4-trifluoromethylphenoxyphenoxy)}ethanol and 2.5 ml of pyridine in 60 ml of dichloroethene. The mixture is stirred for 12 hours under normal pressure and at room temperature. The mixture is then concentrated in vacuo and the residue is taken up in ethyl ether/2M HCI. The organic phase is separated off and then washed once with 2M HCI, twice with aqueous sodium hydrogen carbonate solution and once with sodium chloride solution, dried over sodium sulphate, filtered and concentrated in vacuo to yield 10 g of a viscous oil, which is purified by chromatography on silica gel (1 :2 ethyl ether/n-hexane). After removal of the solvent, 3 g of the title substance are obtained in the form of a light- yellow oil, no23 = 1.491. The examples of formula I given below can be prepared in an analogous manner. The compounds of formula I in those examples are generally obtained in the form of colourless to yellowish oils, and a few are obtained in the form of wax-like products. Ph denotes phenyl.
Table 1 : Preferred sub-group of compounds of formula la
Figure imgf000007_0001
No. R5 Rt R2 physical constant
1.01 H H H CH3 H 2-C3H7n O nD 23 = 1 .531
1.02 H H 2-CI CH3 H H O
1.03 6-CI H 2-CI CH3 H H O
1.04 H H 2-F CH3 H H O nD 23 = 1 .514
1.05 H H 2-F CH3 H H O
1.06 H H 3-CI CH3 H H O
1.07 6-CI 4-CI 2-CI CH3 H H O
1.08 H H H CH3 H 3-CI O
1.09 H H 2-CI CH3 H 3-CI O
1.10 6-CI H 2-CI CH3 5-CI 3-CI O
1.11 H H 2-F CH3 H 3-F O
1.12 H H 2-F CH3 5-F 3-F O
1.13 5-CI H 3-CI CH3 6-CI 3-CI O 1.14 6-CI 4-CI 2-CI CH3 6-CI 2-CI O
1.15 H 4-CH3 H CH3 H H O
1.16 H H 4-CF3 CH3 H H O nD 23 = 1.491
1.17 H 3-NO2 H CH3 H H O
1.18 4-CH3 3-CH3 H CH3 H H O
1.19 H 2-NO2 H CH3 H H O
1.20 H 4-OCH3 H CH3 H H O
1.21 H 4-CIM H CH3 H H O
1.22 5-CI H 3-CI CH3 H H O nD 23 = 1.530
1.23 H 4-t-butyl H CH3 H H O
1.24 H 4-CH3 H CH3 H 3-CI O
1.25 H 4-CF3 H CH3 H 3-F O
1.26 H 3-NO2 H CH3 5-F 3-F O
1.27 4-CH3 3-CH3 H CH3 H 2-CI O
1.28 H 2-NO2 H CH3 H 2-F O
1.29 H 4-OCH3 H CH3 H 2-CH3 O
1.30 H 4-CN H CH3 6-CI 2-CI O
1.31 H 4-F H CH3 5-F 2-F O
1.32 H 4-t-butyl H CH3 H 3-CH3 O
1.33 H H H C2H5 H H O
1.34 H H 2-CI C3H7-n H H O
1.35 6-CI H 2-CI C2H5 H H O
1.36 H H 2-F C2H5 H H O
1.37 H H 2-F C3H7-i H H O
1.38 5-CI H 3-CI C4H9-n H H O 1.39 6-CI 4-CI 2-CI C4Hg-S H H O
Figure imgf000009_0001
1.41 H H 2-CI C3H7-n H 3-CI O
1.42 6-CI H 2-CI C5H10-n 5-CI 3-CI O
Figure imgf000009_0002
1.45 5-CI H 3-CI C4H9-n 6-CI 3-CI O
1.46 6-CI 4-CI 2-CI CβHn-n 6-CI 2-CI O
1.47 H 4-CH3 H C3H7-n H H O
Figure imgf000009_0003
1.50 4-CH3 3-CH3 H C2H5 H H O
Figure imgf000009_0004
1.52 H 4-OCH3 H C3H7-n H H O
1.53 H 4-CN H C H9-n H H O
1.54 H 4-F H C4H9-s H H O
1.55 H 4-t-butyl H C6Hn-n H H O
1.56 H 4-CH3 H C2H5 H 3-CI O
Figure imgf000009_0005
1.58 H 3-NO2 H CsHio-n 5-F 3-F O
1.59 4-CH3 3-CH3 H C3H7-n H 2-CI O
1.60 H 2-NO2 H C4H9-n H 2-F O
1.61 H 4-OCH3 H C2H5 H 2-CH3 O
1.62 H 4-CN H C4H9-t 6-CI 2-CI O
1.63 H 4-F H C H9-s 5-F 2-F O 1.64 H 4-t-butyl H C3H7-i H 3-CH3 O
Figure imgf000010_0001
1.66 H H 2-CI C3H7-n H H S
1.67 6-CI H 2-CI C-2H5 H H S
Figure imgf000010_0002
1.69 H H 2-F C3H7-i H H S
1.70 5-CI H 3-CI C4H9-n H H S
Figure imgf000010_0003
1.72 H H 2-CI C3H7-n H 3-CI S
1.73 6-CI H 2-CI CsHio-n 5-CI 3-CI S
1.74 H H 2-F C6Hι n H 3-F S
Figure imgf000010_0004
1.76 5-CI H 3-CI C4H9-n 6-CI 3-CI S
1.77 6-CI 4-CI 2-CI C6Hι n 6-CI 2-CI S
1.78 H 4-CH3 H C3H7-n H H S
Figure imgf000010_0005
1.81 4-CH3 3-CH3 H C2H5 H H S
Figure imgf000010_0006
1.83 H 4-OCH3 H C3H7-n H H S
1.84 H 4-CN H C4H9-n H H S
1.85 H 4-F H C4H9-s H H S
1.86 H 4-t-butyl H C6Hι n H H S
1.87 H 4-CH3 H C2H5 H 3-CI S
Figure imgf000010_0007
1.89 H 3-NO2 H C5H10-n 5-F 3-F S
1.90 4-CH3 3-CH3 H C3H7-n H 2-CI S
1.91 H 2-NO2 H C4H9-n H 2-F S
1.92 H 4-OCH3 H C2H5 H 2-CH3 S
1.93 H 4-CN H C Hg-t 6-CI 2-CI S
1.94 H 4-F H C4H9-s 5-F 2-F S
1.95 H 4-t-butyl H C3H7-i H 3-CH3 S
1.96 H H H CH3 H H S
1.97 H H 2-CI CH3 H H S
1.98 6-CI H 2-CI CH3 H H S
1.99 H H 2-F CH3 H H S
1.100 H H 2-F CH3 H H S
1.101 5-CI H 3-CI CH3 H H S
1.102 6-CI 4-CI 2-CI CH3 H H S
1.103 H H H CH3 H 3-CI S
1.104 H H 2-CI CH3 H 3-CI S
1.105 6-CI H 2-CI CH3 5-CI 3-CI S
1.106 H H 2-F CH3 H 3-F S
1.107 H H 2-F CH3 5-F 3-F S
1.108 5-CI H 3-CI CH3 6-CI 3-CI S
1.109 6-CI 4-CI 2-CI CH3 6-CI 2-CI s
1.110 H 4-CH3 H CH3 H H s
1.111 H 4-CF3 H CH3 H H s
Figure imgf000011_0001
1.113 4-CH3 3-CH3 H CH3 H H s 1.114 H 2-NO2 H CH3 H H S
1.115 H 4-OCH3 H CH3 H H S
1.116 H 4-CN H CH3 H H S
1.117 H 4-F H CH3 H H S
1.1 18 H 4-t-butyl H CH3 H H S
1.119 H 4-CH3 H CH3 H 3-CI S
Figure imgf000012_0001
1.121 H 3-NO2 H CH3 5-F 3-F S
1.122 4-CH3 3-CH3 H CH3 H 2-CI S
Figure imgf000012_0002
1.124 H 4-OCH3 H CH3 H 2-CH3 S
1.125 H 4-CN H CH3 6-CI 2-CI S
1.126 H 4-F H CH3 5-F 2-F S
1.127 H 4-t-butyl H CH3 H 3-CH3 S
1.128 H H H F H H O
1.129 H H 2-CI F H H O
1.130 6-CI H 2-CI F H H O
1.131 H H 2-F F H H O
1.132 H H 2-F F H H O
1.133 5-CI H 3-CI F H H O
1.134 6-CI 4-CI 2-CI F H H O
1.135 H H H F H 3-CI O
1.136 H H 2-CI F H 3-CI O
1.137 6-CI H 2-CI F 5-CI 3-CI O
1.138 H H 2-F F H 3-F O 1.139 H H 2-F F 5-F 3-F O
1.140 5-CI H 3-CI F 6-CI 3-CI O
1.141 6-CI 4-CI 2-CI F 6-CI 2-CI O
Figure imgf000013_0001
1.144 H 3-NO2 H F H H O
Figure imgf000013_0002
1.148 H 4-CN H F H H O
1.149 H 4-F H F H H O
1.150 H 4-t-butyl H F H H O
1.151 H 4-CH3 H F H 3-CI O
1.152 H 4-CF3 H F H 3-F O
Figure imgf000013_0003
1.154 4-CH3 3-CH3 H F H 2-CI O
Figure imgf000013_0004
1.156 H 4-OCH3 H F H 2-CH3 O
1.157 H 4-CN H F 6-CI 2-CI O
1.158 H 4-F H F 5-F 2-F O
1.159 H 4-t-butyl H F H 3-CH3 O
1.160 H H H Cl H H O
1.161 H H 2-CI Cl H H O
1.162 6-CI H 2-CI Cl H H O
1.163 H H 2-F Br H H O 1.164 H H 2-F Cl H H O
1.165 5-CI H 3-CI Br H H O
1.166 6-CI 4-CI 2-CI Cl H H O
1.167 H H H Cl H 3-CI s
1.168 H H 2-CI Cl H 3-CI s
1.169 6-CI H 2-CI Cl 5-CI 3-CI s
1.170 H H 2-F Br H 3-F s
1.171 H H 2-F Cl 5-F 3-F s
1.172 5-CI H 3-CI Br 6-CI 3-CI s
1.173 6-CI 4-CI 2-CI Cl 6-CI 2-CI s
1.174 H H H F H H NH
1.175 H H 2-CI F H H NCH3
1.176 6-CI H 2-CI F H H NC2H5
1.177 H H 2-F F H H NH
1.178 H H 2-F Cl H H NC6H13-n
1.179 5-CI H 3-CI Cl H H NH
1.180 6-CI 4-CI 2-CI Cl H H NH
1.181 H H 2-F Cl 5-F 3-F NCH3
1.182 5-CI H 3-CI F 6-CI 3-CI NC2H5
1.183 6-CI 4-CI 2-CI F 6-CI 2-CI NC2H5
1.184 H 4-CH3 H F H H NH
1.185 H 4-CF3 H F H H NC4H9-n
Figure imgf000014_0001
1.187 4-CH3 3-CH3 H Cl H H NH
Figure imgf000014_0002
1.189 H 4-OCH3 H Br H H NCH3
1.190 H 4-CN H Cl H H NCH3
Figure imgf000015_0001
1.192 H 4-t-butyl H Cl H H NH
1.193 H 4-CH3 H Cl H 3-CI NCH3
1.194 H 4-CF3 H F H 3-F NH
1.195 H 3-NO2 H F 5-F 3-F NCH3
1.196 4-CH3 3-CH3 H F H 2-CI NH
1.197 H 2-NO2 H Ph H 2-F NC2H5
1.198 H 4-OCH3 H Ph H 2-CH3 NC3H7-n
1.199 H 4-CN H Ph 6-CI 2-CI NCH3
1.200 H 4-F H Ph 5-F 2-F NCH3
1.201 H 4-t-butyl H Ph H 3-CH3 NH
1.202 H H 6-Ph CH3 H H O
1.203 H H 6-Ph CH3 H H S
1.204 3-CI 5-CI H CH3 H H O
1.205 3-CI 5-CI H CH3 H H S
1.206 H 4-C4H9-t H CH3 H H O
1.207 H 4-C4H9-t H CH3 H H S
Table 2: Compounds of formula lb:
Figure imgf000016_0001
No. R5 Z m Ri R2 A physical constant
2.01 H CH3 2 H H O
2.02 2-CI CH3 3 H H O
2.03 2-CI CH3 1 H H O
2.04 2-F CH3 2 H H O
2.05 2-F CH3 1 H H O
2.06 3-CI CH3 2 H H O
2.07 2-CI CH3 3 H H O
2.08 H CH3 1 H 3-CI O
2.09 2-CI CH3 1 H 3-CI O
2.10 2-CI CH3 3 5-CI 3-CI O
2.11 2-F CH3 3 H 3-F O
2.12 2-F CH3 2 5-F 3-F O
2.13 3-CI CH3 3 6-CI 3-CI O
2.14 2-CI CH3 2 6-CI 2-CI O
Figure imgf000016_0002
2.17 H CH3 2 H H NCH3
2.18 H CH3 2 H 3-CI NH 2.19 H CH3 2 H 3-F S
2.20 H CH3 2 5-F 3-F S
Figure imgf000017_0001
2.23 2-CI C3H7-n 2 H H O
Table 3: Compounds of formula Ic
Figure imgf000017_0002
No. R3 R4 Ri R2 -B-O- physical constant
3.01 H H H CH3 H H OC(O)O 3.02 H H 2-CI CH3 H H OC(O)O 3.03 6-CI H 2-CI CH3 H H OC(O)O 3.04 H H 2-F CH3 H H OC(O)O 3.05 H H 2-F CH3 H H OC(O)O 3.06 H H 3-CI CH3 H H OC(O)O 3.07 6-CI 4-CI 2-CI CH3 H H OC(O)O 3.08 H H H CH3 H 3-CI OC(O)O 3.09 H H 2-CI CH3 H 3-CI OC(O)O 3.10 6-CI H 2-CI CH3 5-CI 3-CI OC(O)O 3.1 1 H H 2-F CH3 H 3-F OC(O)O 3.12 H H 2-F CH3 5-F 3-F OC(O)O 3.13 5-CI H 3-CI CH3 6-CI 3-CI OC(O)O 3.14 6-CI 4-CI 2-CI CH3 6-CI 2-CI OC(O)O
3.15 H 4-CH3 H CH3 H H OC(O)O
3.16 H H 3-CF3 CH3 H H OC(O)O
3.17 H 3-NO2 H CH3 H H OC(O)O
3.18 4-CH3 3-CH3 H CH3 H H OC(O)O
3.19 H 2-NO2 H CH3 H H OC(O)O
3.20 H 4-OCH3 H CH3 H H OC(O)O
3.21 H 4-CN H CH3 H H OC(O)O
3.22 5-CI H 3-CI CH3 H H OC(O)O
3.23 H 4-t-butyl H CH3 H H OC(O)O
3.24 H 4-CH3 H CH3 H 3-CI OC(O)O
3.25 H 4-CF3 H CH3 H 3-F OC(O)O
3.26 H 3-NO2 H CH3 5-F 3-F OC(O)O
3.27 4-CH3 3-CH3 H CH3 H 2-CI OC(O)O
3.28 H 2-NO2 H CH3 H 2-F OC(O)O
3.29 H 4-OCH3 H CH3 H 2-CH3 OC(O)O
3.30 H 4-CN H CH3 6-CI 2-CI OC(O)O
3.31 H 4-F H CH3 5-F 2-F OC(O)O
3.32 H 4-t-butyl H CH3 H 3-CH3 OC(O)O
3.33 H H H C2H5 H H OC(O)O
3.34 H H 2-CI C3H7-n H H OC(O)O
3.35 6-CI H 2-CI C2H5 H H OC(O)O
3.36 H H 2-F C2H5 H H OC(O)O
3.37 H H 2-F C3H7-i H H OC(O)O
3.38 5-CI H 3-CI C4H9-n H H OC(O)O 3.39 6-CI 4-CI 2-CI C4H9-s H H OC(O)O
3.40 H H H C2H5 H 3-CI OC(O)O
3.41 H H 2-CI C3H7-n H 3-CI OC(O)O
3.42 6-CI H 2-CI C5H10-n 5-CI 3-CI OC(O)O
3.43 H H 2-F CβHn-n H 3-F OC(O)O
3.44 H H 2-F C2H5 5-F 3-F OC(O)O
3.45 5-CI H 3-CI C4H9-n 6-CI 3-CI OC(O)O
3.46 6-CI 4-CI 2-CI CeHn-n 6-CI 2-CI OC(O)O
3.47 H 4-CH3 H C3H7-n H H OC(O)O
3.48 H 4-CF3 H C2H5 H H OC(O)O
3.49 H 3-NO2 H C2H5 H H OC(O)O
3.50 4-CH3 3-CH3 H C2H5 H H OC(O)O
3.51 H 2-NO2 H C3H7-i H H OC(O)O
3.52 H 4-OCH3 H C3H7-n H H OC(O)O
3.53 H 4-CN H C4H9-n H H OC(O)O
3.54 H 4-F H C H9-s H H OC(O)O
3.55 H 4-t-butyl H C6Hι n H H OC(O)O
3.56 H 4-CH3 H C2H5 H 3-CI OC(O)O
3.57 H 4-CF3 H C2H5 H 3-F OC(O)O
3.58 H 3-NO2 H C5H10-n 5-F 3-F OC(O)O
3.59 4-CH3 3-CH3 H C3H7-n H 2-CI OC(O)O
3.60 H 2-NO2 H C4H9-n H 2-F OC(O)O
3.61 H 4-OCH3 H C2H5 H 2-CH3 OC(O)O
3.62 H 4-CN H C H9-t 6-CI 2-CI OC(O)O
3.63 H 4-F H C Hg-S 5-F 2-F OC(O)O 3.64 H 4-t-butyl H C3H7-i H 3-CH3 OC(O)O
Figure imgf000020_0001
3.66 H H 2-CI C3H7-n H H C(NH)O-
3.67 6-CI H 2-CI C2H5 H H C(NH)O-
3.68 H H 2-F C2H5 H H C(NH)O-
3.69 H H 2-F C3H7-i H H C(NH)O-
3.70 5-CI H 3-CI C4H9-n H H C(NH)O-
3.71 H H H C2H5 H 3-CI C(NH)O-
3.72 H H 2-CI C3H7-n H 3-CI C(NH)O-
3.73 6-CI H 2-CI C5H10-n 5-CI 3-CI C(NH)O-
3.74 H H 2-F CeHn-n H 3-F C(NH)O-
3.75 H H 2-F C2H5 5-F 3-F C(NH)O-
3.76 5-CI H 3-CI C4H9-n 6-CI 3-CI C(NH)O-
3.77 6-CI 4-CI 2-CI C6Hn-n 6-CI 2-CI C(NH)O-
3.78 H 4-CH3 H C3H7-n H H C(NH)O-
3.79 H 4-CF3 H C2H5 H H C(NH)O-
3.80 H 3-NO2 H C2H5 H H C(NH)O-
3.81 4-CH3 3-CH3 H C2Hs H H C(NH)O-
3.82 H 2-NO2 H C3H7-i H H C(NH)O-
3.83 H 4-OCH3 H C3H7-n H H C(NH)O-
3.84 H 4-CN H C4H9-n H H C(NH)O-
3.85 H 4-F H C4Hg-S H H C(NH)O-
3.86 H 4-t-butyl H CβHn-n H H C(NH)O-
3.87 H 4-CH3 H C2Hδ H 3-CI C(NH)O-
3.88 H 4-CF3 H C2H5 H 3-F C(NH)O- 3.89 H 3-NO2 H CsHio-n 5-F 3-F C(NH)O-
3.90 4-CH3 3-CH3 H C3H7-n H 2-CI C(NH)O-
3.91 H 2-NO2 H C4H9-n H 2-F C(NH)O-
3.92 H 4-OCH3 H C2H5 H 2-CH3 C(NH)O-
3.93 H 4-CN H C4Hg-t 6-CI 2-CI C(NH)O-
3.94 H 4-F H C Hg-S 5-F 2-F C(NH)O-
3.95 H 4-t-butyl H C3H7-i H 3-CH3 C(NH)O-
3.96 H H H CH3 H H C(NH)O-
3.97 H H 2-CI CH3 H H C(NH)O-
3.98 6-CI H 2-CI CH3 H H C(NH)O-
3.99 H H 2-F CH3 H H C(NH)O-
3.100 H H 2-F CH3 H H C(NH)O
3.101 5-CI H 3-CI CH3 H H C(NH)O
3.102 6-CI 4-CI 2-CI CH3 H H C(NH)O-
3.103 H H H CH3 H 3-CI C(NH)0-
3.104 H H 2-CI CH3 H 3-CI C(NH)O-
3.105 6-CI H 2-CI CH3 5-CI 3-CI C(NH)O
3.106 H H 2-F CH3 H 3-F C(NH)O
3.107 H H 2-F CH3 5-F 3-F C(NH)O
3.108 5-CI H 3-CI CH3 6-CI 3-CI C(NH)0-
3.109 6-CI 4-CI 2-CI CH3 6-CI 2-CI C(NH)0-
3.110 H 4-CH3 H CH3 H H C(NH)O
3.111 H 4-CF3 H CH3 H H C(NH)O
3.112 H 3-NO2 H CH3 H H C(NH)O
3.113 4-CH3 3-CH3 H CH3 H H C(NH)O 3.1 14 H 2-NO2 H CH3 H H C(NH)O-
3.1 15 H 4-OCH3 H CH3 H H C(NH)O-
3.116 H 4-CN H CH3 H H C(NH)O-
3.1 17 H 4-F H CH3 H H C(NH)O-
3.118 H 4-t-butyl H CH3 H H C(NH)O-
3.119 H 4-CH3 H CH3 H 3-CI C(NH)O-
3.120 H 4-CF3 H CH3 H 3-F C(NH)O-
3.121 H 3-NO2 H CH3 5-F 3-F C(NH)O-
3.122 4-CH3 3-CH3 H CH3 H 2-CI C(NH)O-
3.123 H 2-NO2 H CH3 H 2-F C(NH)O-
3.124 H 4-OCH3 H CH3 H 2-CH3 C(NH)O-
3.125 H 4-CN H CH3 6-CI 2-CI C(NH)O-
3.126 H 4-F H CH3 5-F 2-F C(NH)O-
3.127 H 4-t-butyl H CH3 H 3-CH3 C(NH)O-
3.128 H H H F H H OC(O)O
3.129 H H 2-CI F H H OC(O)O
3.130 6-CI H 2-CI F H H OC(O)O
3.131 H H 2-F F H H OC(O)O
3.132 H H 2-F F H H OC(O)O
3.133 5-CI H 3-CI F H H OC(O)O
3.134 6-CI 4-CI 2-CI F H H OC(O)O
3.135 H H H F H 3-CI OC(O)O
3.136 H H 2-CI F H 3-CI OC(O)O
3.137 6-CI H 2-CI F 5-CI 3-CI OC(O)O
3.138 H H 2-F F H 3-F OC(O)O 3.139 H H 2-F F 5-F 3-F OC(O)O
3.140 5-CI H 3-CI F 6-CI 3-CI OC(O)O
3.141 6-CI 4-CI 2-CI F 6-CI 2-CI OC(O)O
3.142 H 4-CH3 H F H H OC(O)O
3.143 H 4-CF3 H F H H OC(O)O
3.144 H 3-NO2 H F H H OC(O)O
3.145 4-CH3 3-CH3 H F H H OC(O)O
3.146 H 2-NO2 H F H H OC(O)O
3.147 H 4-OCH3 H F H H OC(O)O
3.148 H 4-CN H F H H OC(O)O
3.148 H 4-F H F H H OC(O)O
3.150 H 4-t-butyl H F H H OC(O)O
3.151 H 4-CH3 H F H 3-CI OC(O)O
3.152 H 4-CF3 H F H 3-F OC(O)O
3.153 H 3-NO2 H F 5-F 3-F OC(O)O
3.154 4-CH3 3-CH3 H F H 2-CI OC(O)O
3.155 H 2-NO2 H F H 2-F OC(O)O
3.156 H 4-OCH3 H F H 2-CH3 OC(O)O
3.157 H 4-CN H F 6-CI 2-CI OC(O)O
3.158 H 4-F H F 5-F 2-F OC(O)O
3.159 H 4-t-butyl H F H 3-CH3 OC(O)O
3.160 H H H Cl H H OC(O)O
3.161 H H 2-CI Cl H H OC(O)O
3.162 6-CI H 2-CI Cl H H OC(O)O
3.163 H H 2-F Br H H OC(O)O 3.164 H H 2-F Cl H H OC(O)O
3.165 5-CI H 3-CI Br H H OC(O)O
3.166 6-CI 4-CI 2-CI Cl H H OC(O)O
3.167 H H H Cl H 3-CI C(NH)O-
3.168 H H 2-CI Cl H 3-CI C(NH)O-
3.169 6-CI H 2-CI Cl 5-CI 3-CI C(NH)O-
3.170 H H 2-F Br H 3-F C(NH)O-
3.171 H H 2-F Cl 5-F 3-F C(NH)O-
3.172 5-CI H 3-CI Br 6-CI 3-CI C(NH)O-
3.173 6-CI 4-CI 2-CI Cl 6-CI 2-CI C(NH)O-
It has since been possible to confirm the excellent insecticidal and acaricidal action of the substances disclosed in EP-0 577 555 in in vitro tests and in vivo also in the field of plant protection. By contrast, however, the use, suggested speculatively in EP-0 577 555, of the substances described therein for the protection of domestic animals and productive livestock has proved to be substantially inappropriate because the compounds trigger unacceptable side-effects when administered to productive livestock and domestic animals. The side-effects range from serious skin irritations and necroses to the death of the animals treated. That class of substance therefore appears to be completely unsuitable for use in the field of animal health.
Surprisingly, however, there has been found within that huge class of substances a relatively small specific group of structurally closely related new compounds, namely the compounds of formula I defined at the outset, which does not cause those negative side- effects but, on the contrary, is excellently tolerated by productive livestock and domestic animals even in relatively large amounts and still has excellent activity against insects and representatives of the family of Acarina (arachnids, especially mites and ticks). These unforeseeable advantageous effects on warm-blooded animals could not have been foreseen in any way and, when applied to the field of animal health, can be exploited excellently in the control of ectoparasites. The advantageous effect is clearly associated with the specific chemical structure.
In the context of the present invention, ectoparasites are understood to mean in particular insects, mites and ticks. Included are insects of the following orders: Lepidoptera, Coleoptera, Homoptera, Heteroptera, Diptera, Thysanoptera, Oήhoptera, Psoroptes, Anoplura, Siphonaptera, Mallophaga, Thysanura, Isoptera, Psocoptera and Hymenoptera. Special mention may be made, however, of ectoparasites that trouble humans and animals and transmit pathogens, for example flies, such as Musca domestica, Musca vetustissima, Musca autumnalis, Fannia canicularis, Sarcophaga carnaria, Lucilia cuprina, Hypoderma bovis, Hypoderma lineatum, Chrysomyia chloropyga, Dermatobia hominis, Cochliomyia hominivorax, Gasterophilus intestinalis, Oestrus ovis, Stomoxys calcitrans, Haematobia irritans and midges (Nematocera), such as Culicidae, Simuliidae, Psychodidae, and also bloodsucking parasites, for example fleas, such as Ctenocephalides felis and Ctenocephalides canis (cat and dog fleas), Xenopsylla cheopis, Pulex irritans, Dermatophilus penetrans, lice, such as Damalina ovis, Pediculus humanis, stable flies and horse flies (Tabanidae), Haematopota spp., such as Haematopota pluvialis, Tabanidea spp., such as Tabanus nigrovittatus, Chrysopsinae spp., such as Chrysops caecutiens, tsetse flies, such as Glossinia species, biting insects, especially cockroaches, such as Blatella germanica, Blatta orientalis, Periplaneta americana, mites, such as Dermanyssus gallinae, Sarcoptes scabiei, Psoroptes ovis and Psorergates spp. and finally ticks. The latter belong to the order Acarina. Known examples of ticks are, for example, Boophilus, Amblyomma, Anocentor, Dermacentor, Haemaphysalis, Hyalomma, Ixodes, Rhipicentor, Margaropus, Rhipicephalus, Argas, Otobius and Ornithodoros and the like that preferentially infest warm-blooded animals, including farm animals, such as cows, pigs, sheep and goats, poultry, such as hens, turkeys and geese, animals bred for their fur, such as mink, fox, chinchillas, rabbits and the like, and domestic animals, such as cats and dogs, but also humans.
Ticks may be subdivided into hard and soft ticks and are characterised by the fact that they infest one, two or three host animals. They attach themselves to a suitable host animal and suck blood or body fluid. Fully replete female ticks fall off the host animal and lay large amounts of eggs (2000 to 3000) in a suitable niche in the ground or in any other protected site, where the larvae hatch out. These in turn look for a host animal from which to suck blood. Larvae of ticks that infest only one host animal moult twice and in so doing become nymphs and finally adult ticks without leaving the host animal initially selected. Larvae of ticks that infest two or three host animals fall off after the blood meal, moult in the surrounding area and, as nymphs or adult ticks, look for a second or third host on which to suck.
Ticks are responsible worldwide for carrying and transmitting many human and animal diseases. The most significant ticks, owing to their economic effect, are Boophilus, Rhipicephalus, Ixodes, Hyalomma, Amblyomma and Dermacentor. They are carriers of bacterial, viral, rickettsial and protozoal diseases and cause tick paralysis and tick toxicosis. Just a single tick can cause paralysis as a result of its saliva penetrating the host animal as the tick takes its nourishment. Diseases triggered by ticks are usually carried by ticks that infest a plurality of host animals. Such diseases, for example babesiosis, anaplasmosis and theileriosis, and pericardial fluid are responsible for the death of, or injury to, a large number of domestic and farm animals worldwide. In many countries having a temperate climate, ixodid ticks transmit the agent of chronically damaging Lyme disease from wild animals to humans. In addition to disease transmission, ticks are responsible for large-scale economic loss in livestock production. The losses are attributable not only to the death of the host animals but also to damage to the coats, growth loss, reduction in milk production and the reduced value of the meat. Although the damaging effects of tick infestation on animals have been known for years and enormous progress has been made with tick-control programmes, no completely satisfactory methods for the control or elimination of those parasites have hitherto been found and, furthermore, ticks have often developed resistance to chemical active substances.
The infestation of domestic animals and pets with fleas also still constitutes a problem for animal owners to which the solution is still only inadequate or very expensive. Like ticks, fleas are not only a nuisance but are also disease carriers that, especially in moist-warm climatic regions, for example in the Mediterranean region, the southern part of the USA, etc., transmit various fungal diseases from host animal to host animal and to the animal keeper. Especially at risk are people having a weakened immune system or children whose immune system has not yet fully developed. Owing to the flea's complex life cycle, none of the known methods of controlling them is totally satisfactory, especially since most of the known methods are aimed principally at controlling the fully grown fleas in the coat, and take no account at all of the various juvenile stages of the fleas, which live not only in the animal's coat, but also on the floor, on carpets, on the animal's sleeping place, on chairs, in the garden and in all the other places with which the infested animal comes into contact. Flea treatment is generally expensive and must be continued for prolonged periods, success generally being achieved only when the treatment is applied not only to the affected animal, for example the dog or cat, but also simultaneously to all the places frequented by the affected animal. The compounds of formula I are suitable both for the direct treatment of the animal and for the disinfection of its environment and, owing to the fact that it is well tolerated, also for the treatment of the animal's sleeping place.
The present invention accordingly preferably relates to a method of controlling parasites on or in domestic animals, productive livestock and pets, which method comprises administering an effective amount of a composition that comprises at least one compound of formula I or a physiologically tolerable salt thereof, preferably topically, to an infested warm-blooded animal for curative treatment or to a parasite-free warm-blooded animal for preventative treatment.
Pour-on and spot-on formulations are especially preferred forms of topical administration, but administration in the form of sprays, ointments, solutions, baths or powders may also be expedient.
When used according to the invention, the compound of formula I according to the invention will normally be administered not in pure form but preferably in the form of a composition that comprises, in addition to the active ingredient, constituents that assist administration, suitable constituents being those which are tolerated by the host animal. The control according to the invention covers both the adult parasites and the juvenile stages of the parasites. Further active substances may of course be added to such compositions in order to broaden the spectrum of activity of the active ingredient.
Such compositions to be administered in accordance with the invention generally comprise from 0.1 to 99% by weight, especially from 0.1 to 95% by weight, of a compound of formula I according to the invention and from 99.9 to 1 % by weight, especially from 99.9 to 5% by weight, of a solid or liquid, physiologically tolerable carrier, including from 0 to 25% by weight, especially from 0.1 to 25% by weight, of a non-toxic dispersant. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ dilute formulations.
Such compositions may comprise further additives, such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as other active ingredients for obtaining special effects.
The physiologically tolerable carriers known from veterinary medicinal practice for oral, percutaneous and topical administration can be used as formulation auxiliaries. Some examples are given below.
Suitable carriers are especially fillers, such as sugars, for example lactose, saccharose, mannitol or sorbitol, cellulose preparations and/or calcium phosphates, for example tricalcium phosphate or calcium hydrogen phosphate, and binders, such as starch pastes using, for example, maize, wheat, rice or potato starch, gelatins, tragacanth, methyl cellulose and/or, if desired, disintegrators, such as the above-mentioned starches, also carboxymethyl starch, crosslinked polyvinylpyrrolidone, agar, alginic acid or a salt thereof, such as sodium alginate. Adjuvants are especially flow regulators and lubricants, for example silicic acid, talc, stearic acid or salts thereof, such as magnesium or calcium stearate, and/or polyethylene glycol. Dragee cores can be provided with suitable, optionally enteric, coatings, there being used, inter alia, concentrated sugar solutions which may comprise gum arabic, talc, polyvinylpyrrolidone, polyethylene glycol and/or titanium dioxide, or coating solutions in suitable organic solvents or solvent mixtures or, for the preparation of enteric coatings, solutions of suitable cellulose preparations, such as acetyl cellulose phthalate or hydroxypropylmethylcellulose phthalate. Dyes, flavourings or pigments may be added to the tablets or dragee coatings, for example for identification purposes or to indicate different doses of active ingredient.
The preferred pour-on or spot-on method comprises applying the compound of formula I to a locally defined area of the skin or coat, advantageously on the back of the neck or the backbone of the animal. This is carried out, for example, by applying a swab or squirt of the pour-on or spot-on formulation to a relatively small area of the coat from where the active ingredient becomes distributed over a wide area of the coat almost automatically, as a result of the spreading constituents of the formulation and assisted by the movements of the animal.
Pour-on and spot-on formulations advantageously comprise carriers that promote rapid distribution over the surface of the skin or in the coat of the host animal and are generally termed spreading oils. There are suitable, for example, oily solutions; alcoholic and isopropanolic solutions, e.g. solutions of 2-octyldodecanol or oleyl alcohol; solutions in esters of monocarboxylic acids, such as isopropyl myristate, isopropyl palmitate, lauric acid oxalic ester, oleic acid oleyl ester, oleic acid decyl ester, hexyl laurate, oleyl oleate, decyl oleate, capric acid esters of saturated fatty alcohols of chain length C12-Cι8; solutions of esters of dicarboxylic acids, such as dibutyl phthalate, diisopropyl isophthalate, adipic acid diisopropyl ester, di-n-butyl adipate or solutions of esters of aliphatic acids, e.g. glycols. It may be advantageous for a dispersant known from the pharmaceutical or cosmetic industry also to be present. Examples are pyrrolidin-2-one, N-alkylpyrrolidin-2-one, acetone, polyethylene glycol and its ethers and esters, propylene glycol and synthetic triglycerides.
The oily solutions include e.g. vegetable oils, such as olive oil, groundnut oil, sesame oil, pine oil, linseed oil and castor oil. The vegetable oils may also be in epoxidised form. It is also possible to use paraffins and silicone oils.
Generally a pour-on or spot-on formulation will contain from 1 to 20% by weight of a compound of formula (I), from 0.1 to 50% by weight of dispersant and from 45 to 98.9% by weight of solvent.
The pour-on or spot-on method can be used especially advantageously for herd animals, such as cattle, horses, sheep and pigs, where it is difficult or time-consuming to treat all the animals orally or via injection. By virtue of its simplicity, this method can of course also be used for all other animals, including individual domestic animals and pets, and is very popular with the keepers of animals because it can often be carried out without the expert assistance of a veterinary surgeon. The preparations of the present invention can be prepared in a manner known per se, for example by means of conventional processes.
The following Examples and patent claims illustrate the invention described above but do not limit its scope in any way. Temperatures are given in degrees Celsius. In the following Formulation Examples, the expression "compound of formula I" denotes a compound from the Tables, especially 4-methyl-5,5-difluoropent-4-enoic acid 2-{[4-(4-trifluoromethyl- phenoxy)phenoxy}ethyl ester.
Formulation Examples
Example: Pour-on
A. compound of formula 1 10% epoxidised soybean oil 5% oleyl alcohol 85%
B. compound of formula 1 20% pyrrolidin-2-one 15% isopropyl myristate 65%
C. compound of formula 1 5 g isopropyl myristate 10 g isopropanol ad 100 ml
D. compound of formula 1 2 g hexyl laurate 5 g medium-chain triglycerides 15 g ethanol ad 100 ml E. compound of formula I 2 g oleyl oleate 5 g
N-methylpyrrolidone 40 g isopropanol ad 100 ml
The constituents are mixed and ground with one another until homogeneous.
Suspension concentrates: compound of formula I : from 5 to 75 %, preferably from 10 to 50 % water: from 94 to 24 %, preferably from 88 to 30 % surfactant: from 1 to 40 %, preferably from 2 to 30 %
Further biologically active substances or additives that behave neutrally towards the compounds of formula I and have no detrimental effect upon the host animal to be treated, as well as mineral salts or vitamins may be added to the compositions described.
The compositions may also comprise further additives, such as stabilisers, e.g. vegetable oils or epoxidised vegetable oils (epoxidised coconut oil, rape oil or soybean oil), antifoams, e.g. silicone oil, preservatives, viscosity regulators, binders and tackifiers, as well as fertilisers, or other active ingredients for obtaining special effects.
Further preparations comprising active ingredients of formula I can also be prepared analogously to the formulations described.
The compounds of formula I according to the invention can be used alone or in combination with other biocides. For example, in order to enhance their effect they can be combined with pesticides having the same direction of action or in order to broaden the spectrum of activity they can be combined with substances having a different direction of action. It may also be advantageous to add repellents. Where it is desired to broaden the spectrum of activity to endoparasites, e.g. worms, the compounds of formula I are advantageously combined with substances having endoparasiticidal properties. They can, of course, also be used in combination with anti-bacterial compositions. Since the compounds of formula I are 31
"adulticides", that is to say they are effective especially against the fully grown stages of the target parasites, it can be highly advantageous to add pesticides that attack the juvenile stages of the parasite as well. In that manner most of the parasites causing substantial economic damage are targeted. This also helps considerably in avoiding the development of resistance. Some combinations can also produce synergistic effects, which means that the total amount of active substance used can be reduced, which is desirable from the ecological standpoint. Preferred groups of combination partners and especially preferred combination partners are mentioned hereinbelow, it being possible for combinations to comprise, in addition to a compound of formula I, one or more such partners.
Suitable mixing partners are biocides, such as the insecticides and acaricides mentioned hereinbelow that are sufficiently well known to the person skilled in the art and that have various action mechanisms, e.g. chitin synthesis inhibitors, growth regulators; active ingredients that act like juvenile hormones; active ingredients that act as adulticides; broad- spectrum insecticides, broad-spectrum acaricides and nematicides; and also the sufficiently well known anthelmintics and substances that repel insects and/or acarina, so-called repellents and detachers. Non-limiting examples of suitable insecticides and acaricides are:
(I) aldicarb; (XVI) diflubenzuron; (XXXI) parathion-methyl;
(II) azinphos-methyl; (XVII) endosulfan; (XXXII) phosalone;
(III) benfuracarb; (XVIII) ethiofencarb; (XXXIII) pirimicarb;
(IV) bifenthrin; (XIX) fenitrothion; (XXXIV) propoxur;
(V) buprofezin; (XX) fenobucarb; (XXXV) teflubenzuron;
(VI) carbofuran; (XXI) fenvalerate; (XXXVI) terbufos;
(VII) dibutylaminothio; (XXII) formothion; (XXXVII) triazamate;
(VIII) cartap; (XXIII) methiocarb; (XXXVIII) abamectin;
(IX) chlorfluazuron; (XXIV) heptenophos; (XXXIX) fenobucarb;
(X) chlorpyrifos; (XXV) imidacloprid; (XL) tebufenozide;
(XI) cyfluthrin; (XXVI) isoprocarb; (XLI) fipronil;
(XII) lambda-cyhalothrin; (XXVII) methamidophos; (XLII) beta-cyfluthrin;
(XIII) alpha-cypermethrin; (XXVIII) methomyl; (XLIII) silafluofen;
(XIV) zeta-cypermethrin; (XXIX) mevinphos; (XLIV) fenpyroximate;
(XV) deltamethrin; (XXX) parathion; (XLV) pyridaben; (XLVI) fenazaquin; (XLVIII) pyπmidifen; (L) NI-25, acetamipπd;
(XLVII) pyπproxyfen; (XLIX) nitenpyram;
(LI) avermectin Bi;
(Lll) an insect-active extract from a plant;
(Llll) a preparation comprising insect-active nematodes;
(LIV) a preparation obtainable from Bacillus subtilis;
(LV) a preparation comprising insect-active fungi;
(LVI) a preparation compπsing insect-active viruses,
(LVI!) AC 303 630; (LXXXI) chlormephos; (CVI) fenothiocarb; (LVIII) acephate; (LXXXII) cis-res-methπn, (CVII) fenpropathπn; (LIX) acrinathπn; (LXXXIII) clocythπn, (CVIII) fenpyrad; (LX) alanycarb; (LXXXIV) clofentezme, (CIX) fenthion, (LXI) alphamethπn, (LXXXV) cyanophos, (CX) fluazinam; (LXII) amitraz; (LXXXVI) cycloprothnn; (CXI) flucycloxuron; (LXIII) AZ 60541 , (LXXXVII) cyhexatm; (CXII) flucythnnate; (LXIV) azinphos A; (LXXXVIII) demeton-M, (CXIII) flufenoxuron; (LXV) azinphos M, (LXXXIX) demeton-S, (CXIV) flufenprox; (LXVI) azocyclotin; (XC) demeton-S-methyl, (CXV) fonophos; (LXVII) bendiocarb; (XCI) dichlofenthion; (CXVI) fosthiazate; (LXVIII) bensultap; (XCII) dic phos; (CXVII) fubfenprox, (LXIX) beta-cyfluthnn, (XCIII) diethion, (CXVIII) HCH; (LXX) BPMC; (XCIV) dimethoate, (CXIX) hexaflumuron; (LXXI) brofenprox; (XCV) dimethylvinphos, (CXX) hexythiazox; (LXXil) bromophos A; (XCVI) dioxathion, (CXXI) iprobenfos; (LXXIII) bufencarbe; (XCVII) edifenphos, (CXXII) isofenphos; (LXXIV) butocarboxin; (XCVIII) emamectin, (CXXIII) isoxathion; (LXXV) butylpyndaben, (XCIX) esfenvalerate, (CXXIV) ivermectm; (LXXVI) cadusafos; (C) ethion; (CXXV) lambda- (LXXVII) carbaryl; (Cl) ethofenprox; cyhalothπn; (LXXVIII) carbopheno- (Cll) ethoprophos; (CXXVI) malathion; thion; (Clll) etπmphos; (CXXVII) mecarbam; (LXXIX) chloethocarb; (CIV) fenamiphos; (CXXVIII) mesulfenphos; (LXXX) chlorethoxyfos; (CV) fenbutatine oxide; (CXXIX) metaldehyde; (CXXX) metolcarb; (CLXII) temephos; (CXXXI) milbemectin; (CLXIII) terbam; (CXXXII) moxidectin; (CLXIV) tetrachlor- (CXXXIII) naled; vinphos; (CXXXIV) NC 184; (CLXV) thiafenox; (CXXXV) omethoate; (CLXVI) thiodicarb; (CXXXVI) oxamyl; (CLXVII) thiofanox; (CXXX VI I) oxydeme- (CLXVIII) thionazin; thon M; (CLXIX) thuringiensin; (CXXXVIII) oxydeprofos; (CLXX) tralomethrin; (CXXXIX) permethrin; (CLXXI) triarthen; (CXL) phenthoate; (CLXXII) triazophos; (CXLI) phorate; (CLXXIII) triazuron; (CXLII) phosmet; (CLXXIV) trichlorfon; (CXLIII) phoxim; (CLXXV) triflumuron; (CXLIV) pirimiphos M; (CLXXVI) trimethacarb; (CXLV) pirimiphos A; (CLXXVII) vamidothion; (CXLVI) promecarb; (CLXXVIII) xylyicarb; (CXLVII) propaphos; (CLXXIX) Yl 5301/5302; (CXLVIII) prothiofos; (CLXXX) zetamethrin; (CXLIX) prothoate; (CLXXXI) DPX-MP062; (CL) pyrachlophos; (CLXXXII) RH-2485; (CLI) pyridaphenthion; (CLXXXIII) D 2341 ; (CLII) pyresmethrin; (CLXXXIV) XMC (3,5-xy- (CLIII) pyrethrum; lyl methylcarbamate), (CLIV) RH 5992; (CLXXXV) lufenuron (CLV) salithion; (CLXXXVI) fluazuron (CLVI) sebufos; (CLXXXVII) methoprene (CLVII) sulfotep; (CLXXXVIII) hydroprene (CLVIII) sulprofos; (CLXXXIX) fenoxycarb (CLIX) tebufenpyrad; (CXC) chlorfenapyr or (CLX) tebupirimphos; (CXCI) spinosad (CLXI) tefluthrin; (CXCII) thiamethoxam Non-limiting examples of suitable anthelmintics are mentioned hereinbelow, a number of the examples thereof having, in addition to anthelmintic activity, also an insecticidal and acaricidal activity, some of them already being mentioned in the list above:
(A1) praziquantel = 2-cyclohexylcarbonyl-4-oxo-1 ,2,3,6,7, 11 b-hexahydro-4H-pyrazino[2,1- jisoquinoline (A2) closantel = 3,5-diiodo-N-[5-chloro-2-methyl-4-(α-cyano-4-chlorobenzyl)phenyl]salicyl- amide (A3) triclabendazole = 5-chloro-6-(2,3-dichlorophenoxy)-2-methylthio-1 H-benzimidazole (A4) levamisol = -(-)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1b]thiazole (A5) mebendazole = (5-benzoyl-1 H-benzimidazol-2-yl)carbamic acid methyl ester (A6) omphalotin = a macrocyclic fermentation product of the fungus Omphalotus olearius described in WO 97/20857 (A7) abamectin = avermectin B1 (A8) ivermectin = 22,23-dihydroavermectin B1 (A9) moxidectin = 5-O-demethyl-28-deoxy-25-(1 ,3-dimethyl-1 -butenyl)-6,28-epoxy-23-
(methoxyimino)-milbemycin B (A10) doramectin = 25-cyclohexyl-5-O-demethyl-25-de(1 -methylpropyl)-avermectin A1a (A11) milbemectin = mixture of milbemycin A3 and milbemycin A4 (A12) milbemycinoxim = 5-oxime of milbemectin
Non-limiting examples of suitable repelling substances (repellents and detachers) are:
(R1) DEET (N,N-diethyl-m-toluamide)
(R2) KBR 3023 N-butyl-2-oxycarbonyl-(2-hydroxy)-piperidine
(R3) cvmiazole = N,-2,3-dihydro-3-methyl-1 ,3-thiazol-2-ylidene-2,4-xylidene
The mentioned mixing partners are well known to persons skilled in the art. Most of them are described in various editions of the Pesticide Manual, The British Crop Protection Council, London, while others are described in various editions of The Merck Index, Merck & Co., Inc., Rahway, New Jersey, USA or in the patent literature. The following list is therefore restricted to a few references given by way of example.
(I) 2-methyl-2-(methylthio)propionaldehyde O-methylcarbamoyloxime (aldicarb), from The Pesticide Manual, 11th Ed. (1997), The British Crop Protection Council, London, page 26; (II) S-(3,4-dihydro-4-oxobenzo[o]-[1 ,2,3]-triazin-3-ylmethyl) O,O-dimethyl phosphorodithioate (azinphos-methyl), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 67;
(III) ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl-(methyl)aminothio]-N- isopropyl-β-alaninate (benfuracarb), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 96;
(IV) 2-methylbiphenyl-3-ylmethyl (Z)-(1 flS)-c/'s-3-(2-chloro-3,3,3-trifluoroprop-1 -enyl)-2,2- dimethylcyclopropanecarboxylate (bifenthrin), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 1 18;
(V) 2-tert-butylimino-3-isopropyl-5-phenyl-1 ,3,5-thiadiazian-4-one (buprofezin), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 157;
(VI) 2,3-dihydro-2,2-dimethylbenzofuran-7-yl methylcarbamate (carbofuran), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 186;
(VII) 2,3-dihydro-2,2-dimethylbenzofuran-7-yl (dibutylaminothio)methylcarbamate
(carbosulfan), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 188;
(VIII) S,S'-(2-dimethylaminotrimethylene) bis(thiocarbamate) (cartap), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 193;
(IX) 1-[3,5-dichloro-4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl]-3-(2,6-difluorobenzoyl)- urea (chlorfluazuron), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 213;
(X) 0,0-diethyl 0-3,5,6-trichloro-2-pyridyl phosphorothioate (chlorpyrifos), from The Pesticide Manual, 11,hEd. (1997), The British Crop Protection Council, London, page 235;
(XI) (r?S)-α-cyano-4-fluoro-3-phenoxybenzyl (1 r?S,3flS;1 flS,3ftS)-3-(2,2-dichlorovinyl)-2,2- dimethylcyclopropanecarboxylate (cyfluthrin), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 293;
(XII) mixture of (S)-α-cyano-3-phenoxybenzyl (2)-(1 r?,3ri)-3-(2-chloro-3,3,3-trifluoro- propenyl)-2,2-dimethylcyclopropanecarboxylate and (f?)-α-cyano-3-phenoxybenzyl (Z)- (1r?,3 :?)-3-(2-chloro-3,3)3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (lambda-cyhalothrin), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 300;
(XIII) racemate consisting of (S)- -cyano-3-phenoxybenzyl (1 fl,3R)-3-(2,2-dichlorovinyl)-2,2- dimethylcyclopropanecarboxylate and (/^-α-cyano-S-phenoxybenzyl (1 S,3S)-3-(2,2- dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (alpha-cypermethrin), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 308;
(XIV) a mixture of the stereoisomers of (S)-α-cyano-3-phenoxybenzyl (1 RS,3RS,1 RS,3RS)- 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (zeta-cypermethrin), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 314;
(XV) (S)-α-cyano-3-phenoxybenzyl (1 fl,3/^-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropane- carboxylate (deltamethrin), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 344;
(XVI) (4-chlorophenyl)-3-(2,6-difluorobenzoyl)urea (diflubenzuron), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 395;
(XVII) (1 ,4,5,6,7,7-hexachloro-8,9, 10-trinorbom-5-en-2,3-ylenebismethylene) sulf ite (endosulfan), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 459;
(XVIII) α-ethylthio-o-tolyl methylcarbamate (ethiofencarb), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 479;
(XIX) 0,0-dimethyl O-4-nitro-m-tolyl phosphorothioate (fenitrothion), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 514;
(XX) 2-sec-butylphenyl methylcarbamate (fenobucarb), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 516;
(XXI) (HS)-α-cyano-3-phenoxybenzyl (f>S)-2-(4-chlorophenyl)-3-methylbutyrate (fenvalerate), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 539;
(XXII) S-[formyl(methyl)carbamoylmethyl] 0,0-dimethyl phosphorodithioate (formothion), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 625;
(XXIII) 4-methylthio-3,5-xylyl methylcarbamate (methiocarb), from The Pesticide Manual, H^Ed. (1997), The British Crop Protection Council, London, page 813; (XXIV) 7-chlorobicyclo[3.2.0]hepta-2,6-dien-6-yl dimethylphosphate (heptenophos), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 670;
(XXV) 1 -(6-chloro-3-pyridylmethyl)-Λ/-nitroimidazolidin-2-ylidenamine (imidacloprid), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 706;
(XXVI) 2-isopropylphenyl methylcarbamate (isoprocarb), from The Pesticide Manual, 1 1,hEd. (1997), The British Crop Protection Council, London, page 729;
(XXVII) 0,S-dimethyl phosphoramidothioate (methamidophos), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 808;
(XXVIII) S-methyl Λ/-(methylcarbamoyloxy)thioacetimidate (methomyl), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 815;
(XXIX) methyl 3-(dimethoxyphosphinoyloxy)but-2-enoate (mevinphos), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 844;
(XXX) 0,0-diethyl O-4-nitrophenyl phosphorothioate (parathion), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 926;
(XXXI) 0,0-dimethyl O-4-nitrophenyl phosphorothioate (parathion-methyl), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 928;
(XXXII) S-6-chloro-2,3-dihydro-2-oxo-1 ,3-benzoxazol-3-ylmethyl 0,0-diethyl phosphorodithioate (phosalone), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 963;
(XXXIII) 2-dimethylamino-5,6-dimethylpyrimidin-4-yl dimethylcarbamate (pirimicarb), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 985;
(XXXIV) 2-isopropoxyphenyl methylcarbamate (propoxur), from The Pesticide Manual, 11lhEd. (1997), The British Crop Protection Council, London, page 1036;
(XXXV) 1 -(3,5-dichloro-2,4-difluorophenyl)-3-(2,6-difluorobenzoyl)urea (teflubenzuron), from The Pesticide Manual, H^Ed. (1997), The British Crop Protection Council, London, page 1158;
(XXXVI) S-tert-butylthiomethyl 0,0-dimethyl phosphorodithioate (terbufos), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 1165; (XXXVII) ethyl (3-ferf-butyl-1 -dimethylcarbamoyl-1 H-1 ,2,4-triazol-5-yl-thio)-acetate, (triazamate), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 1224;
(XXXVIII) abamectin, from The Pesticide Manual, 1 1,hEd. (1997), The British Crop Protection Council, London, page 3;
(XXXIX) 2-sec-butylphenyl methylcarbamate (fenobucarb), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 516;
(XL) N-fe/?-butyl-/V-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide (tebufenozide), from The
Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 1 147; (XLI) (±)-5-amino-1 -(2,6-dichloro-α,α,α-trifluoro-p-tolyl)-4-trifluoromethyl-sulfinylpyrazole-3- carbonitrile (fipronil), from The Pesticide Manual, 1 1thEd. (1997), The British Crop
Protection Council, London, page 545; (XLI!) (flS)-α-cyano-4-fluoro-3-phenoxybenzyi (1 RS,3r?S;1 f?S,3r?S;-3-(2,2-dichlorovinyl)-
2,2-dimethylcyclopropanecarboxylate (beta-cyfluthrin), from The Pesticide Manual,
11thEd. (1997), The British Crop Protection Council, London, page 295; (XLIII) (4-ethoxyphenyl)-[3-(4-fluoro-3-phenoxyphenyl)propyl](dimethyl)silane (silafluofen), from The Pesticide Manual, 1 1 hEd. (1997), The British Crop Protection Council, London, page 1 105; (XLIV) terf-butyl (E)-α-(1 ,3-dimethyl-5-phenoxypyrazol-4-yl-methylenamino-oxy)-p-toluate
(fenpyroximate), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection
Council, London, page 530; (XLV) 2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2/-/)-one (pyridaben), from
The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 1 161 ; (XLVI) 4-[[4-(1 ,1 -dimethylphenyl)phenyl]ethoxy]-quinazoline (fenazaquin), from The
Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 507; (XLVII) 4-phenoxyphenyl (r?S)-2-(pyridyloxy)propyl ether (pyriproxyfen), from The Pesticide
Manual, 11thEd. (1997), The British Crop Protection Council, London, page 1073; (XLVIII) 5-chloro-/V-{2-[4-(2-ethoxyethyl)-2,3-dimethylphenoxy]ethyl}-6-ethylpyrimidin-4- amine (pyrimidifen), from The Pesticide Manual, H^Ed. (1997), The British Crop
Protection Council, London, page 1070; (XLIX) (E)-Λ/-(6-chloro-3-pyridylmethyl)-Λy-ethyl-Λ/-methyl-2-nitrovinylidenediamine (nitenpyram), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 880;
(L) (E)-Λ/1-[(6-chloro-3-pyridyl)methyl]-/v?-cyano-Λ/1-methylacetamidine (NI-25, acetamiprid), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 9;
(LI) avermectin B^ from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 3;
(Lll) an insect-active extract from a plant, especially (2R,6aS,12aS)-1 ,2,6,6a,12,12a- hexahydro-2-isopropenyl-8,9-dimethoxy-chromeno[3,4-D]furo[2,3- 7]chromen-6-one (rotenone), from The Pesticide Manual, 1 1 Ed. (1997), The British Crop Protection Council, London, page 1097; and an extract from Azadirachta indica, especially azadirachtin, from The Pesticide Manual, 1 1 thEd. (1997), The British Crop Protection Council, London, page 59; and
(Llll) a preparation comprising insect-active nematodes, preferably Heterorhabditis bacteriophora and Heterorhabditis megidis, from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 671 ; Steinernema feltiae, from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 1 115, and Steinernema scapterisci, from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 1 116;
(LIV) a preparation obtainable from Bacillus subtilis, from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 72; or from a Bacillus thuringiensis strain with the exception of compounds isolated from GC91 or from NCTC1 1821 ; The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 73;
(LV) a preparation comprising insect-active fungi, preferably Verticillium lecanii, from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 1266; Beauveria brogniartii, from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 85; and Beauveria bassiana, from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 83;
(LVI) a preparation comprising insect-active viruses, preferably Neodipridon SertiferNPV, from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 1342; Mamestra brassicae NPV, from The Pesticide Manual, 1 1^Ed. (1997), The British Crop Protection Council, London, page 759; and Cydia pomonella granulosis virus, from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council,
London, page 291 ; (CLXXXI) 7-chloro-2,3,4a,5-tetrahydro-2-[methoxycarbonyl(4-trifluoromethoxyphenyl)- carbamoyl]indole[1 ,2e]oxazoline-4a-carboxylate (DPX-MP062, indoxycarb), from The
Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 453; (CLXXXII) Λ -tert-butyl-Λ -(3,5-dimethylbenzoyl)-3-methoxy-2-methylbenzohydrazide (RH-
2485, methoxyfenozide), from The Pesticide Manual, 1 1 hEd. (1997), The British Crop
Protection Council, London, page 1094; and (CLXXXIII) (Λ/'-[4-methoxy-biphenyl-3-yl]-hydrazinecarboxylic acid isopropyl ester (D 2341), from the Brighton Crop Protection Conference, 1996, 487- 493; (R2) Book of Abstracts, 212th ACS National Meeting Orlando, FL, August 25-29 (1996),
AGRO-020. Publisher: American Chemical Society, Washington, D.C. CONEN: 63BFAF.
Given the above, a further substantial aspect of the present invention relates to combination preparations for the control of parasites on warm-blooded animals, which combination preparations comprise, in addition to a compound of formula I, at least one further active ingredient having the same direction of action or a different direction of action and at least one physiologically tolerable carrier. The present invention is not limited to combinations of two constituents.
Biological Examples
Example 1 : Tolerability study on sheep after pour-on application
Completely healthy female sheep aged 4 to 5 months and having a body weight of approximately from 33 to 34 kg are shorn bald on the back and, for the purpose of clear identification, are provided with numbered eartags; for the entire duration of the test they are kept in separate pens with slatted floors. A small group remains untreated and serves as the control. All the sheep are given the customary standard feed apportioned according to their age, and water as desired. On day 0, from 33 to 34 ml of a pour-on formulation according to Example B (50 mg of test substance/kg of body weight) are applied to the back of each sheep. In order to detect any unusual behaviour or local side-effects, the sheep are observed continuously on the day of treatment. Blood samples are taken 6 hours after treatment and once each morning on the days that follow and are evaluated according to the following parameters. Blood values Chemical values erythrocytes (RBC) aspartate aminotransferase (ASAT) haemoglobin (HB) alanine aminotransferase (ALAT) mean cell volume (HCT) creatine kinase (CK/NAC) mean cell-haemoglobin (MCH) γ-glutamate transpeptidase (G-GT) mean cell-haemoglobin concentration total bilirubin (TBILI)
(MCHC) leucocytes (WBC) creatinine (CREA) blood platelets (PLT) glucose (GLUC) blood platelets (PLT) glutamate dehydrogenase (GLDH) blood-urea-nitrogen (BUN) total protein (TOT. PROTEIN) albumin (ALB) globulin (GLOB) sodium (NA) potassium (K) calcium (CA) magnesium (MG)
After pour-on application, the test substances do not at any time prove to cause local side- effects and the blood and chemical values measured show a range of variation absolutely identical to that for the untreated control animals. The compounds of formula I, e.g. compounds 1.01 , 1.06, 1.16, 1.22 and 3.01 , prove to be well tolerated up to a dose of 50 mg/kg under the test conditions.
Example 2: In vivo activity against mange mites on sheep after pour-on application Healthy sheep having an average body weight of approximately 35 kg are artificially infested, between the shoulder blades and in the groin area, with mange (Psoroptes ovis) of all stages of development. After 3 weeks, approximately 90% of the sheep have infested areas of skin of about 25 - 50 cm2. The infested sheep are selected for the remaining tests and, in order to be able to distinguish clearly between them, they are provided with numbered eartags. For the entire duration of the test, the sheep are kept in individual pens (0.9 x 1.2 m) having a slatted grid floor. They are fed with approximately 0.7 kg of maize and approximately 0.2 kg of hay per day and have access to drinking water. 8 sheep are treated; 2 remain untreated and serve as the control group. An aqueous emulsion having a final concentration of test substance of 500 ppm is used for the treatment. The treatment is carried out by careful wetting of the infested sites, care being taken to ensure that the emulsion wets the wool and also the underlying areas of skin thoroughly. Approximately 1 litre of emulsion is used per sheep. The effectiveness of the test substances is assessed at 14-day intervals over a period of from 6 to 8 weeks by reference to the extent of the infested regions. The changes are assessed in relation to the situation at the outset, with the infestation directly before the start of treatment representing 100%. In parallel, the behaviour of the test animals is recorded. Completely analogous tests are carried out with dilute test emulsions (100 ppm).
The evaluation shows that, at a concentration of 500 ppm, compounds of formula I from Tables 1 and 2, e.g. compounds 1.01 , 1.06, 1.16, 1.22 and 3.01 , completely eliminate the infestation within a maximum of 48 days, i.e. no surviving mites can be found and the damaged areas of skin show the healing process to be progressing. With a number of examples, e.g. compound no. 1.16, this result is achieved even at a dilution of the test substance to 100 ppm. None of the treated animals exhibits undesirable side-effects; they behave absolutely normally throughout the entire duration of the test.
Example 3: In vivo action against mouse mites by topical treatment Mice infested with mites (Myocopetes musculinus and Myobia musculi) are anaesthetised and studied under a stereomicroscope to determine the density of the mite population. The mice are divided into groups having the same index of infestation, that is to say each having the same mite population, the index consisting of a scale from 1 (no mites) to 30 (greatest mite density). For the purposes of the test, only mice that score at least 25 on the said scale (high mite density) are used. The test substance is applied to the coat in the form of a solution, suspension or emulsion as a pour-on formulation, that is to say, topically. The dose is in the range from 32 to 0.1 mg/kg of body weight. 150 μl of the solution, suspension or emulsion are applied to each mouse along the line of the back. The effectiveness is evaluated 7, 28 and 56 days after application by comparing the infestation index after treatment with that before treatment. The effectiveness result is given as a percentage reduction in the mite population. In this test, compounds of formula I from Tables 1 to 3, for example compounds 1.01 , 1.06, 1.16, 1.22 and 3.01 , at a dilution of up to 10 mg/kg of body weight, exhibit a more than 80% reduction in mite infestation and show no negative side- effects even at the highest active ingredient concentrations.

Claims

What is claimed is:
1. A compound of formula I
Figure imgf000045_0001
wherein, when n is 0, at least one of the two phenyl rings is substituted;
R1 and R2 are each independently of the other hydrogen, halogen, cyano, nitro, Cι- alkyl,
Cι- haloalkyl, Cι-4alkoxy, C1- haloalkoxy or benzyl;
A is oxygen, sulfur or -N(R6)-, wherein R6 is Cι.4alkyl, phenylthio or tolylthio;
B is -C(O)-, -O-C(O)- or -C(N-R6)-, wherein n is 0 or 1 and R6 is hydrogen or C1- alkyl; p is an integer from 1 to 10;
R3, R4 and R5 are each independently of the others hydrogen, halogen, cyano, nitro, C haloalkyl, Cι- alkoxy or Cι.4haloalkoxy; or R3 and R4 are adjacent to one another and together with the phenyl ring to which they are bonded form a naphthyl group; m is 0, 1 , 2 or 3; and Z is Cι.6alkyl, phenyl or halogen; in free form or in the form of a physiologically tolerable salt.
2. A compound of formula I according to claim 1 , wherein R and R2 are hydrogen; A is oxygen; n is 1 ; m is 2; p is 3; and Z is CH3 or F.
3. A compound of formula I according to claim 1 , derived from the sub-group of formula la
Figure imgf000045_0002
wherein R and R2 are each independently of the other hydrogen, halogen or Cι- alkyl; A is oxygen, sulfur or -N(R6)-, wherein R6 is C1-4alkyl; R3, R4 and R5 are each independently of the others hydrogen, halogen, cyano, nitro, Cι.4alkyl or C1- alkoxy; and Z is Cι.6alkyl, phenyl or halogen; in free form or in the form of a physiologically tolerable salt.
4. A compound of formula I according to claim 3, wherein R, and R2 are each independently of the other hydrogen, fluorine, chlorine or Cι.4alkyl; with the proviso that both are not simultaneously hydrogen; A is oxygen; R3, R4 and R5 are each independently of the others hydrogen, fluorine, chlorine, CF3, cyano or nitro; and Z is CH3, phenyl, fluorine or chlorine; in free form or in the form of a physiologically tolerable salt.
5. A process for the preparation of a compound of formula I according to any one of claims 1 to 4, which comprises reacting a compound of formula II
Figure imgf000046_0001
wherein R, R^ R2, B, A, n and m are as defined for formula I, in the presence or absence of an inert solvent or solvent mixture, with a compound of formula III
Figure imgf000046_0002
wherein Q is hydroxy or halogen and p is as defined for formula I, preferably chlorine or bromine; and Z and p are as defined for formula I; the reaction preferably being carried out in the presence of a hydrophilic agent or of a catalyst when Q is hydroxy, and preferably being carried out in the presence of an acid-binding agent when Q is halogen.
6. A composition for controlling ectoparasites on a domestic animal, productive livestock or a pet, which comprises, in addition to inert auxiliaries and carriers, at least one compound of formula I according to claim 1 as active ingredient.
7. A process for the preparation of a composition according to claim 6, which comprises intimately mixing a compound of formula I according to claim 1 with inert auxiliaries and carriers.
8. A method of controlling ectoparasites on a domestic animal, productive livestock or pet, which comprises applying a compound according to any one of claims 1 to 4 or a composition according to claim 6 to the ectoparasites or to their habitat.
9. A method according to claim 8, which comprises applying a compound of formula I according to any one of claims 1 to 4 in the form of a pour-on formulation to the coat of a domestic animal, of productive livestock or of a pet.
10. Use of a compound of formula I according to any one of claims 1 to 4 in the preparation of an ectoparasiticidal composition for domestic animals, productive livestock or pets.
11. A combination preparation for controlling parasites in or on warm-blooded animals, which comprises, in addition to a compound of formula I according to claim 1 , at least one further active ingredient having the same direction of action or a different direction of action and at least one physiologically tolerable carrier.
PCT/EP2000/011470 1999-11-19 2000-11-17 Carbonic acid derivatives and their use as ectoparasiticidal composition WO2001036371A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU21601/01A AU2160101A (en) 1999-11-19 2000-11-17 Carbonic acid derivatives and their use as ectoparasiticidal composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH211599 1999-11-19
CH2115/99 1999-11-19

Publications (1)

Publication Number Publication Date
WO2001036371A1 true WO2001036371A1 (en) 2001-05-25

Family

ID=4226234

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/011470 WO2001036371A1 (en) 1999-11-19 2000-11-17 Carbonic acid derivatives and their use as ectoparasiticidal composition

Country Status (2)

Country Link
AU (1) AU2160101A (en)
WO (1) WO2001036371A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0577555A1 (en) * 1992-06-30 1994-01-05 Ciba-Geigy Ag Derivatives of carboxylic acids

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0577555A1 (en) * 1992-06-30 1994-01-05 Ciba-Geigy Ag Derivatives of carboxylic acids

Also Published As

Publication number Publication date
AU2160101A (en) 2001-05-30

Similar Documents

Publication Publication Date Title
RU2245877C2 (en) Substituted nitrovinylaminocarbamates, their preparing and composition for control of blood-sucking insects
RU2259370C2 (en) Aminoheterocyclamide derivatives eliciting pesticide activity
AU2005219559B2 (en) Use of pyrimidine compounds in the preparation of parasiticides
US6620767B1 (en) Pesticidal n-heteroaryl alpha-alkoximino-carboxamides
US6667326B1 (en) Pesticidal aminoheterocyclamide compounds
WO2001036371A1 (en) Carbonic acid derivatives and their use as ectoparasiticidal composition
WO2001036372A1 (en) Organic compounds and their use in the control of ectoparasites
WO2001036367A2 (en) Organic compounds
MXPA01012085A (en) 4-substituted milbemycin derivatives.
ZA200103747B (en) Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase